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1 Introduction 
1.1 Pattern-recognition receptors in innate immunity 
Mammals have evolved a variety of innate and adaptive immune responses to 
eliminate invading pathogens. The innate immune system relies on phagocytic and 
non-haematopoietic cells and innate immune responses are characterized by 
recognition of invariant structural signatures of the micro-organisms, so-called 
microbe-associated molecular patterns (MAMPs), by germline-encoded pattern-
recognition receptors (PRRs) (Medzhitov 2007). MAMPs include bacterial cell wall 
components like lipopolysaccharide (LPS), peptidoglycan (PGN), lipoteichoic acid 
and cell wall lipoproteins or flagellin, bacterial and viral nucleic acids and fungal 
constituents. Alternatively, some PRRs are also activated by parasites and danger-
associated molecular patterns (DAMPs), which are generally compartmentalized host 
molecules that delocalize or are produced upon cell damage, like ATP, reactive 
oxygen species (ROS), DNA, or uric acid, but they also include bacterial toxins and 
crystals. There are at least four different classes of PRRs: Toll-like receptors (TLRs), 
retinoic acid-inducible gene (RIG)-I-like receptors (RLRs), C-type lectin receptors 
(CLRs), and nucleotide-binding domain and leucine-rich repeat containing proteins 
(NLRs) (see Figure 1.1). They show distinct sub-cellular localization and specifically 
recognize extracellular, vesicular or cytosolic MAMPs and DAMPs. PRR signalling 
mainly leads to activation of a common set of transcription factors: NF-B and AP-1 
(activator protein 1) induce transcription of pro-inflammatory cytokines, chemokines 
and antimicrobial peptides, whereas interferon (IFN) regulatory factors (IRFs) induce 
type I IFN-dependent antiviral responses.  
TLRs are amongst the best studied PRRs (Kawai and Akira 2010). They comprise 
extracellular leucine-rich repeats mediating ligand binding, transmembrane domains 
and intracellular Toll-interleukin-1 (IL-1) receptor (TIR) domains, which transmit 
downstream signalling. So far, 10 TLRs have been identified in man. They reside in 
the plasma membrane or in endosomal membranes and recognize LPS, lipopeptides 
or flagellin and other MAMPs in the extracellular space or viral dsRNA, ssRNA and 
DNA within endosomes. TLRs activate NF-B, AP-1 and IRFs resulting in the 
transcription of pro-inflammatory cytokines and type I IFNs. 
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Figure 1.1: Pattern-recognition receptors 
Overview of the PRRs and their signalling pathways: Membrane-bound TLRs (white), membrane-
bound Dectin-1 as an example for CLRs (green), cytosolic nodosome and inflammasome NLRs 
(CARD-containing NLRs in blue, PYD-containing NLRs in red), the cytosolic RLRs and the DNA-
sensors AIM2 and IFI16 (light green). Important adaptor proteins are shown.  
 
Viruses are not only recognized by TLRs but also by intracellular PRRs. The RLRs 
RIG-I and melanoma differentiation associated gene 5 (MDA5) both detect viral RNA. 
They contain two N-terminal CARD domains and interact upon RNA recognition via 
homotypic CARD-CARD interactions with the adaptor protein mitochondrial antiviral-
signalling protein (MAVS; also known as IPS-1, Cardif or VISA). MAVS is bound to 
the mitochondrial outer-membrane and interaction with RIG-I or MDA5 leads to NF-
B and IRF3/7 activation (O'Neill and Bowie 2010, Takeuchi and Akira 2010). RIG-I 
has also been shown to interact with ASC (apoptosis-associated speck-like protein 
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containing a CARD) leading to inflammasome formation (see below), caspase-1 
activation and pro-IL-1 processing (Poeck, et al. 2010).  
The first cytosolic DNA sensor being discovered was DNA-dependent activator of 
IRFs (DAI, also called ZBP1) (Takaoka, et al. 2007). Recently, two other DNA 
sensors – absent in melanoma 2 (AIM2) and interferon--inducible protein 16 (IFI16) 
– were detected. Both are pyrin and HIN domain-containing protein (PYHIN) family 
members and comprise a DNA-binding HIN200 domain and an N-terminal pyrin 
domain (PYD) mediating association with ASC. Recognition of dsDNA by AIM2 
results in inflammasome formation (see below), caspase-1 activation and pro-IL-1 
processing as well as induction of pyroptosis (Burckstummer, et al. 2009, Fernandes-
Alnemri, et al. 2009, Hornung, et al. 2009, Roberts, et al. 2009). IFI16 activates IRF3 
and NF-b via the adaptor protein stimulator of interferon genes (STING) 
(Unterholzner, et al. 2010) and also forms ASC-dependent inflammasomes after 
recognition of Kaposi Sarcoma-associated herpes virus (KSHV) DNA in the nucleus 
(Kerur, et al. 2011).  
Another viral sensor is protein kinase R (PKR; also known as RNA-dependent protein 
kinase). PKR is activated by binding to dsRNA and subsequently phosphorylates 
translation initiation factor eIF2, which inhibits further mRNA translation and viral 
protein synthesis (Davis and Watson 1996). PKR also activates NF-B by 
phosphorylation of NF-B inhibitor. IFN signalling elicited upon virus recognition by 
the PRRs described above enhances transcription of PKR and other antiviral proteins 
like ribonuclease L (RNaseL) and oligoadenylate synthetase (OAS) (summarized in 
(Boo and Yang 2010)). OAS is activated by binding to dsRNA. Activated OAS 
converts ATP into 2’, 5’-linked oligomers of adenosine, which bind and activate 
RNaseL. RNaseL subsequently degrades viral ssRNA but also some self mRNA, 
which can serve as a ligand for RIG-I and MDA5. 
CLRs are transmembrane receptors and recognize extracellular carbohydrates of 
bacteria, viruses or fungi. CLR activation results in the production of pro-inflammatory 
cytokines.  
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1.2 NOD-like receptors 
In the last decade another class of intracellular PRRs, the nucleotide-binding domain 
and leucine-rich repeat containing protein family (NLR) has been discovered 
(Franchi, et al. 2009, Magalhaes, et al. 2011). NLRs are characterized by a tripartite 
domain architecture similar to human apoptotic protease-activating factor 1 (APAF1). 
The N-terminal effector domain mediates downstream signal transduction of 
activated NLRs via homotypic protein-protein interactions and adopts a death domain 
fold, which is either a caspase activating and recruitment domain (CARD), a pyrin 
(PYD), or a baculovirus inhibitory repeat (BIR) domain. Some NLR proteins (like 
NLRC5 and NLRX1), however, show no obvious homology to any of these specific 
domains. Based on their N-terminal domain NLRs are classified into different sub-
groups (Ting, et al. 2008a) (see Figure 1.2). The effector domain is followed by a 
central nucleotide-binding domain (NBD), which includes an ATPase domain (see 
chapter 1.2.3) and is necessary for oligomerization upon ligand recognition. The NBD 
consists of the NACHT (domain present in NAIP, CIITA, HET-E and TP1), winged 
helix (WH) and superhelical (SH) domain. The WH and SH domains together are 
sometimes called the NACHT-associated domain (NAD). The C-terminal leucine-rich 
repeats (LRRs) are thought to function in auto-regulation and MAMP recognition, 
although direct MAMP-LRR interaction for NLR proteins remains elusive.  
Several PYD-containing NLRs are reported to form large multiprotein complexes 
called inflammamsomes and function similar to apoptosomes (Schroder and Tschopp 
2010). Whereas the latter activate pro-apoptotic caspases to trigger apoptosis, 
inflammasomes activate pro-inflammatory caspases (human caspase-1, -4, and -5) 
(Martinon and Tschopp 2007). The best characterized inflammasome-forming NLR is 
NLRP3. Various MAMPs, DAMPs, whole pathogens and environmental irritants are 
known to activate NLRP3 (reviewed in (Schroder and Tschopp 2010)), making direct 
ligand binding unlikely. NLRP3 activation leads to oligomerization via the NBD 
domain, recruitment of the adaptor protein ASC followed by recruitment of pro-
caspase-1. Auto-activation of pro-caspase-1 leads to processing and secretion of IL-
1 and IL-18.  
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Figure 1.2: The human NLR family 
Domain architecture of the 22 human NLR proteins and the NLR-relative APAF1 is shown. The 
number of LRRs or WD40 repeats differs from each other, NLR proteins also differ in length. Protein 
names are according to the standard nomenclature (Ting, et al. 2008a), aliases are in brackets. 
AD, acidic activation domain; BIR, baculovirus inhibitory repeat; CARD, caspase activating and 
recruitment domain; LRR, leucine-rich repeat; NBD, nucleotide-binding domain; PYD, pyrin domain. 
Figure adapted from (Kufer and Sansonetti 2011). 
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An additional C-terminal CARD domain makes NLRP1 inflammasome formation 
independent of ASC, although the presence of ASC enhanced caspase-1 activation 
(Faustin, et al. 2007). NLRC4 (IPAF) inflammasomes are also independent of ASC, 
as NLRC4 belongs to the CARD-containing NLRs (Poyet, et al. 2001). However, 
some pathogens triggering NLRC4 inflammasome formation require ASC for full 
caspase-1 activation, although the role of ASC remains unclear (Mariathasan, et al. 
2004, Franchi, et al. 2007, Suzuki, et al. 2007). Apart from IL-1 processing some 
inflammasomes can also induce a form of caspase-1-dependent programmed cell 
death called pyroptosis (Bergsbaken, et al. 2009), characterized by loss of plasma 
membrane integrity (Ting, et al. 2008b).  
Although most NLRs act in pathogen recognition, such a function has not yet been 
identified for class II major histocompatibility complex (MHC) transactivator (CIITA), 
one of the founding members of the NLR family. CIITA has long been recognized to 
regulate MHC class II gene expression by acting as a scaffold for assembly of DNA-
binding transcription factors and histone modifiers in the nucleus (Steimle, et al. 
1993, Zika and Ting 2005). Expression of MHC class II genes is likely mainly 
controlled by CIITA levels that are induced upon IFN- treatment (Harton and Ting 
2000). CIITA nuclear localization and transcriptional activity are dependent on GTP-
binding and a functional Walker A box (Harton, et al. 1999).  
Relatives of NLR proteins are also found in plants (Jones and Dangl 2006, Lukasik 
and Takken 2009). The majority of plant resistance (R) proteins belong to the NB-
LRR family containing a central NBD domain and C-terminal LRRs. Either a TIR 
domain (as in TLRs) or a coiled-coil (CC) region is present at the N-terminus. The 
first layer of plant innate defence is the MAMP-triggered immunity (MTI) 
characterized by detection of extracellular pathogens by membrane-bound PRRs. 
Pathogens have evolved mechanisms to avoid recognition by delivering pathogen 
effectors (also called avirulence genes) that suppress the immune response. These 
effectors are detected by R proteins representing the second layer of plant defence 
responses, the so called effector triggered immunity (ETI). Induction of MTI and ETI 
result in rapid ion fluxes, oxidative burst and transcriptional reprogramming, whereas 
ETI also induces programmed cell death at the site of infection, the hypersensitive 
response (HR), to restrict pathogen colonization. 
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1.2.1 NOD1 and NOD2 signalling 
NOD1 and NOD2 belong to the first NLR proteins identified (Inohara, et al. 1999, 
Ogura, et al. 2001b). Both are members of the NLRC sub-group harbouring one or 
two CARD domains at their N-terminus, respectively. Their localization is mainly 
cytoplasmic, but both are also recruited to the plasma membrane (McDonald, et al. 
2005, Lecine, et al. 2007, Kufer, et al. 2008). Of note, signalling competence seems 
to be crucial for NOD2 membrane localization (Barnich, et al. 2005a). NOD1 and 
NOD2 recognize breakdown products of bacterial PGN: Whereas NOD2 senses 
muramyl dipeptide (MDP) (Girardin, et al. 2003b, Inohara, et al. 2003), present in 
nearly all Gram-positive and Gram-negative bacteria, NOD1 specifically recognizes 
meso-diaminopimelic acid (mDAP)-containing PGN fragments (Chamaillard, et al. 
2003, Girardin, et al. 2003a), which are found in most Gram-negative and only in 
certain Gram-positive bacteria like Listeria and Bacillus species. NOD1 and NOD2 
are thought to reside in an inactive auto-repressed state in the cytosol and ligand 
sensing results in conformational changes allowing homo-oligomerization via the 
NACHT domain to form the signalling-active complex called nodosome. 
NOD1 and NOD2 oligomerization is followed by recruitment of receptor-interacting 
protein 2 (RIP2; also called RICK) via CARD-CARD interactions (Inohara, et al. 1999, 
Ogura, et al. 2001b) and auto-activation of RIP2 by induced proximity (Inohara, et al. 
2000) (overview of the signalling pathway depicted in Figure 1.3). RIP2 kinase 
activity is dispensable for downstream signalling, but is important for RIP2 stability 
(Windheim, et al. 2007, Hasegawa, et al. 2008, Nembrini, et al. 2009). K63-linked 
ubiquitination of RIP2 at K209 is necessary for recruitment of the ubiquitin-binding 
proteins TAK1-binding protein 1 (TAB1), TAB2 and/or TAB3 in a complex with TAK1 
(transforming growth factor- activated kinase 1) (Abbott, et al. 2007, Hasegawa, et 
al. 2008). E3 ligases mediating RIP2 ubiquitination with K63- but also K48-linked 
ubiquitin chains are cellular inhibitor of apoptosis proteins 1 and 2 (cIAP1/2), ITCH 
and putatively X-linked inhibitor of apoptosis (XIAP) (Bertrand, et al. 2009, Krieg, et 
al. 2009, Tao, et al. 2009). NF-B essential modulator (NEMO; also known as IKK) 
is recruited to the intermediate region of RIP2 (Hasegawa, et al. 2008) and is 
subsequently ubiquitinated at K285 (Abbott, et al. 2004) involving TRAF6 (Abbott, et 
al. 2007). Subsequently, IB kinase  (IKK and IKK bind to NEMO (Inohara, et al. 
2000, Girardin, et al. 2001) and are phosphorylated by the auto-activated serine 
8  |  INTRODUCTION 
threonine kinase TAK1 (Shim, et al. 2005). The activated IKK complex 
phosphorylates the NF-B inhibitor IB, targeting it for poly-ubiquitination (Liu and 
Chen 2011). Ubiquitinated IB is degraded by the 26S proteasome allowing NF-B 
to localize to the nucleus and initiate target gene transcription.  
 
 
Figure 1.3: NOD2 signalling pathway 
NOD2 signalling pathway including positive (green) and negative (red) regulators is shown. RIP2 and 
NEMO ubiquitination sites are indicated. Apart from certain regulators, the NOD2 signalling pathway 
depicted here is in principal the same as for NOD1. Refer to text for more details. 
 
Dependent on RIP2 and TAK1, NOD1 and NOD2 also activate the mitogen-activated 
protein (MAP) kinases p38, c-Jun N-terminal kinase (JNK) and extracellular signal-
regulated kinase (ERK), although the signalling pathways are not well resolved 
(Kobayashi, et al. 2005, da Silva Correia, et al. 2007a, Park, et al. 2007a). At least for 
NOD2-mediated p38 activation involvement of CARD9 has been shown (Hsu, et al. 
2007). MAPK signalling results in the activation of AP-1 transcription factors. The 
activation of NF-B and AP-1 mediated by NOD1 and NOD2 signalling leads to 
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secretion of pro-inflammatory cytokines and chemokines and to the production of 
antimicrobial peptides (Franchi, et al. 2009).  
Several mediators of the signalling pathway have been identified, although many 
more factors affecting NOD2 signalling are known. A20 broadly suppresses pro-
inflammatory signalling and also inhibits NOD1- and NOD2-induced NF-B activation 
by de-ubiquitination of RIP2 (Hasegawa, et al. 2008, Hitotsumatsu, et al. 2008), 
whereas CYLD has been shown to de-ubiquitinate NEMO (Abbott, et al. 2004). Heat-
shock protein (HSP) 90 and SGT1 are linked with R protein function in plant defence. 
Both NOD1 and NOD2 interact with the SGT1/HSP90 complex. Inhibition of HSP90 
decreased NOD2-mediated signalling (Mayor, et al. 2007) and reduced NOD1 and 
NOD2 protein levels (da Silva Correia, et al. 2007b). However, SGT1 is only essential 
for NOD1 signalling but dispensable for NOD2 activation (da Silva Correia, et al. 
2007b). 
The GTPase-activating protein Centaurin 1 (CENTB1), a member of the ADP-
ribosylation factor family binds NOD1 and NOD2 and down-regulates NOD-specific 
NF-B activation (Yamamoto-Furusho, et al. 2006). Erbin specifically binds NOD2 at 
the plasma membrane and inhibits NOD2-mediated NF-B activation and cytokine 
secretion (McDonald, et al. 2005, Kufer, et al. 2006b). Both, Erbin and CENTB1 are 
up-regulated in response to NOD2 activation supporting a negative regulatory role. 
Rac1, which is involved in cytoskeletal reorganisation, and its guanine nucleotide 
exchange factor -PIX both interact with NOD2 in a MDP-dependent manner. They 
recruit NOD2 to the plasma membrane leading to negative regulation of NOD2 
signalling by enabling interaction with Erbin (Eitel, et al. 2008). Inhibition of the 
NOD2-Rac1 interaction and disruption of the actin cytoskeleton both enhance NOD2 
signalling (Legrand-Poels, et al. 2007) indicating that membrane recruitment is 
important for negative regulation. The angio-associated migratory cell protein 
(AAMP) binds NOD2 and negatively regulates NF-B activation (Bielig, et al. 2009), 
whereas GRIM-19 (gene associated with retinoid-interferon-induced mortality 19) is 
required for NOD2-mediated NF-B activation and bacterial clearance (Barnich, et al. 
2005b). MEKK4 and Caspase-12 interfere with NOD2-RIP2 and RIP2-TRAF6 
interaction, respectively, and thereby negatively influence NF-B activation (Clark, et 
al. 2008, LeBlanc, et al. 2008). Two NOD2 isoforms are reported to impair NOD2 
signalling. NOD2-C2, containing the two CARD domains reduces MDP-induced 
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NOD2 WT-mediated NF-B activation (Kramer, et al. 2010). NOD2-S possessing a 
complete CARD1 and a truncated CARD2 competes with NOD2-RIP2 binding 
thereby inhibiting NF-B activation (Rosenstiel, et al. 2006).  
NOD2 has also been shown to activate the non-canonical NF-B pathway via the NF-
B-inducing kinase (NIK) in macrophages (Pan, et al. 2006) and to interact with the 
NAD(P)H oxidase family member DUOX2 at the plasma membrane of intestinal 
epithelial cells to induce ROS production, required for direct bactericidal activity 
(Lipinski, et al. 2009). Furthermore, NOD2 has also been reported to be involved in 
antiviral signalling. It interacts with 2’-5’-oligoadenylate synthetase type 2 (OAS2) 
(see above) and can enhanced RNaseL activity in response to poly I:C (Dugan, et al. 
2009). Additionally, NOD2 has been suggested to detect viral ssRNA, leading to 
IRF3-mediated type-I IFN responses. This involves the mitochondrial protein MAVS, 
which is also critical for IFN signalling by the RLRs RIG-I and MDA5 (Sabbah, et al. 
2009).  
NOD1 and NOD2 are both involved in inducing autophagy in response to bacterial 
infection by recruiting the key autophagy regulator ATG16L1 to the entry foci of 
invading bacteria (Cooney, et al. 2009, Travassos, et al. 2009). This response is 
independent of NF-B activation, while the involvement of RIP2 is under debate.  
 
1.2.2 NOD1 and NOD2 in bacterial infection and disease 
Although several studies show that NOD1 and NOD2 are involved in sensing 
pathogenic and non-pathogenic bacteria in vitro, much less is known about their in 
vivo function in host defence. NOD1 deficient mice intragastrically infected with the 
non-invasive pathogen Helicobacter pylori have higher bacterial loads compared to 
wild type mice (Viala, et al. 2004). H. pylori recognition by NOD1 relies on a cag 
pathogenicity island encoding a type IV secretion system to deliver PGN into the host 
cell (Viala, et al. 2004). NOD2 has been shown to be crucial for detection of invasive 
Listeria monocytogenes in the intestine. NOD2 deficient mice orally infected with L. 
monocytogenes are more susceptible to infection, have a higher bacterial load and 
impaired -defensin production compared to wild type mice (Kobayashi, et al. 2005). 
The mechanisms how NOD1 and NOD2 ligands enter the cytosol are poorly 
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understood. Apart from the bacterial secretion systems described above, there is 
also evidence that PGN fragments are delivered into the cytosol by pore-forming 
bacterial toxins (Ratner, et al. 2007), via endocytosis (Marina-Garcia, et al. 2009), 
selective plasma membrane transporters (Ismair, et al. 2006, Swaan, et al. 2008) and 
bacterial outer-membrane vesicles (OMVs) (Kaparakis, et al. 2009, Bielig, et al. 
2011).  
NOD1 and NOD2 function together with TLRs in bacterial sensing. Several 
publications show synergistic production of pro-inflammatory cytokines upon 
stimulation with TLR and NOD1 or NOD2 agonists (Chamaillard, et al. 2003, Fritz, et 
al. 2005, Tada, et al. 2005, Park, et al. 2007b). As a form of protection against 
overwhelming cytokine production TLR ligands induce a transient state of tolerance 
against subsequent TLR stimulation and also continued MDP stimulation induces 
refractoriness to NOD1 and NOD2 agonists (Kim, et al. 2008a). Recent publications 
have revealed that macrophages and mice rendered tolerant to TLR stimulation 
remained responsive to NOD1 and NOD2 stimulation (Kim, et al. 2008b). This 
indicates the importance of NOD1 and NOD2 function when TLR signalling is 
silenced i.e. in the gastrointestinal tract. NOD1 and NOD2 are also implicated in the 
induction of adaptive immunity. Both have been shown to have adjuvant activity, 
mediate T cell differentiation (Kobayashi, et al. 2005, Fritz, et al. 2007) and are 
important for neutrophil recruitment upon bacterial infections (Frutuoso, et al. 2010, 
Hasegawa, et al. 2011).  
Mutations in nod2 (CARD15) have the strongest predisposition for the development 
of Crohn’s disease (CD) in the western population (Hugot, et al. 2001, Ogura, et al. 
2001a). About 30 % of the patients suffering from CD harbour mutations in nod2 
(Hruz and Eckmann 2010). CD is a chronic inflammatory bowel disease (IBD) of the 
gastrointestinal mucosa characterized by aphthous lesions, ulceration and transmural 
granulomatous inflammation (Hruz and Eckmann 2010). About 80 % of the known 
nod2 mutations are associated with CD (Lecat, et al. 2010), with NOD2 1007fs (also 
called NOD2 3020insC or NOD2fs) being the most frequent (8.2 %) (Ogura, et al. 
2001a). Other mutations are linked with early onset sarcoidosis (EOS) and Blau 
syndrome (BS), two auto-inflammatory disorders (Lecat, et al. 2010). EOS- and BS-
associated mutations mostly affect the NBD domain and show increased basal NF-
B activation. In contrast, CD-associated mutations are usually located near or within 
12  |  INTRODUCTION 
the LRRs and lead to a loss-of-function phenotype. Several publications demonstrate 
decreased cytokine production by different cell types harbouring the NOD2fs 
mutation in response to MDP (Inohara, et al. 2003, Netea, et al. 2004, Netea, et al. 
2005, Kramer, et al. 2006), impaired -defensin production in the inflamed 
gastrointestinal tract of CD patients with the NOD2fs mutation (Wehkamp, et al. 
2004) as well as accumulation of bacterial endotoxin in the intestinal tissue (Kosovac, 
et al. 2010). NOD2fs also fail to recruit ATG16L1 to the plasma membrane leading to 
impaired clearance of invasive bacteria by autophagy (Travassos, et al. 2009). 
However, CD is characterized by high levels of NF-B activation and TNF 
production, and both anti-TNF therapy as well as NF-B inhibitors are efficient in 
treating CD (Hruz and Eckmann 2010). This would rather suggest that CD-associated 
NOD2 mutations are gain-of-function mutations and promote inflammatory 
responses. Accordingly, a study using NOD2fs knock-in mice reported increased NF-
B activation in response to MDP (Maeda, et al. 2005). These different findings 
illustrate the still unresolved role of NOD2 in CD and indicate the complexity 
underlying CD development.  
In contrast, polymorphisms in nod1 (CARD4) are mainly found in the non-coding 
region and are associated with increased development of atopic eczema and 
asthma, along with increased serum IgE levels (Hysi, et al. 2005, Weidinger, et al. 
2005). However, the mechanism by which NOD1 variants increase susceptibility to 
develop allergic diseases is unknown.  
 
1.2.3 AAA+ ATPases 
The apoptotic protease-activating factor 1 (APAF1) activates pro-caspase-9 
downstream of mitochondria to induce apoptosis. Crystal structures revealed that 
APAF1 resides in an auto-inhibited, monomeric, ADP-bound state (Li, et al. 1997, 
Riedl, et al. 2005, Reubold, et al. 2011). Upon intrinsic cell death stimuli, cytrochrome 
c is released from mitochondria and binds to the C-terminal WD40 repeats of APAF1. 
This induces conformational changes, leading to the formation of an oligomeric 
signalling complex called apoptosome via the NBD domains (Riedl, et al. 2005, 
Reubold, et al. 2011). APAF1 has been shown to hydrolyse ATP (Riedl, et al. 2005), 
but the exact role of ATP hydrolysis in the activation process remains unclear. Since 
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no high resolution structural data on NLRs are available to date, the current model of 
NLR activation is deducted from APAF1 and from in vitro studies on purified NLRP1, 
NLRP3, NLRP12, and NLRC4 (Lu, et al. 2005, Duncan, et al. 2007, Faustin, et al. 
2007, Ye, et al. 2008). Based on these data Danot et al. proposed a model for 
STAND ATPases (see below) comprising the following steps: (I) elicitor recognition, 
(II) conformational changes leading to a semi-opened state, (III) nucleotide exchange 
(ATP for ADP) to drive oligomerization, and (IV) deactivation of the signalling platform 
by ATP hydrolysis (Danot, et al. 2009).  
APAF1 as well as all NLR proteins are members of the STAND (signal transduction 
ATPases with numerous domains) clade within the AAA+ (ATPases associated with 
various cellular activities) ATPase superfamily. Nucleotide binding and hydrolysis by 
STAND ATPases is mediated by conserved residues within the ATPase domain, 
most prominently the Walker A (P-loop) and B box (Hanson and Whiteheart 2005, 
Proell, et al. 2008). The Walker A box lysine (GxxxxGK[S/T]; x, any amino acid) 
interacts with a phosphate moiety of ATP (see also Table 1, page 59). The canonical 
Walker B box (hhhhD[D/E]; h, hydrophobic amino acid) consists of two acidic 
residues, where the first co-ordinates a Mg2+ ion required for ATP hydrolysis and the 
second primes a H2O molecule for the hydrolysis reaction (Iyer, et al. 2004). NLR 
proteins with the exception of NAIP and NLRP11, however, contain a modified 
Walker B box lacking the second acidic residue. Instead, in most NLR proteins, 
including NOD1 and NOD2, the canonical Walker B box is followed by a conserved 
patch of acidic residues, the extended Walker B box (D[GAS]hDE) (Proell, et al. 
2008). Other ATPase motifs are the Sensor 1, which co-ordinates an ATP -
phosphate, whereas the conserved proline in the GxP motif is thought to interact with 
the adenine moiety. The AAA+ ATPase motif Sensor 2 is lacking in STAND clade 
ATPases. It is replaced by the WH domain in APAF1 and especially the conserved 
histidine is involved in co-ordinating the ADP -phosphate group (Riedl, et al. 2005). 
Structural alignments revealed that this is also the case for NLRs (Proell, et al. 2008).  
 
1.3 TRIM proteins 
Tripartite motif-containing (TRIM) proteins are present in all metazoans, although the 
number varies between species (Sardiello, et al. 2008). They are involved in a broad 
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range of biological processes like cell proliferation, differentiation, development, 
morphogenesis and apoptosis and many TRIM proteins are expressed in response to 
IFNs (Rajsbaum, et al. 2008, Carthagena, et al. 2009). Members of the TRIM protein 
superfamily possess a RBCC motif at the N-terminus, which consists of a RING 
(really interesting new gene) and one or two B-box domains followed by a coiled-coil 
(CC) region.  
RING domains are zinc-binding domains and represent the major type of E3 ligases 
in eukaryotes. E3 ligases mediate the conjugation of proteins with ubiquitin, small 
ubiquitin-like modifier (SUMO) or the ubiquitin-like molecule IFN-stimulated protein of 
15 kDa (ISG15) (Bailly, et al. 1997, Deshaies and Joazeiro 2009). Ubiquitin is a small 
8.5 kDa protein that can be attached by an isopeptide bond between the ubiquitin C-
terminal carboxyl group and the N-terminal or lysine (K) -amino group of target 
proteins. This results in either mono-ubiquitination or poly-ubiquitination, where the 
ubiquitin molecules are linked by internal lysines to form chains. Protein 
ubiquitination plays an important role in the regulation of a range of cellular 
processes, depending on the linkage type. Assembly of at least four ubiquitin 
molecules linked via K48 typically targets proteins for proteasomal degradation by 
the 26S proteasome (Hershko and Ciechanover 1998), whereas mono-ubiquitination 
and K63-linked chains are associated with the modification of signal transduction 
processes (reviewed in (Chen and Sun 2009)). The ubiquitination pathway involves 
activation of ubiquitin by an E1 ubiquitin-activating enzyme and ubiquitin transfer 
from E1 to an E2 ubiquitin-conjugating enzyme. The E3 ubiquitin ligase interacts with 
ubiquitin-bound E2 and the target protein, bringing them into close proximity to 
induce ubiquitin transfer from E2 to the target (Deshaies and Joazeiro 2009). The E3 
ubiquitin ligase activity is crucial for many TRIMs to mediate their effect on signalling 
pathways as demonstrated in vitro for several TRIM proteins in conjunction with 
specific E2s (Napolitano, et al. 2011).  
The B-box domains are also zinc-binding motifs, but B-box 1 and 2 differ in their 
consensus sequences. They are unique for TRIMs and structurally related to the 
RING domain. TRIM proteins either contain one or both B-boxes, although B-box 1 is 
never present without B-box 2. No overall function has been ascribed to this domain, 
but they seem to be involved in viral recognition by some TRIM proteins and 
mutations within the B-boxes of TRIM18 (also called midline 1, MID1) are associated 
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with X-linked Opitz syndrome (Ozato, et al. 2008). The CC region mediates TRIM 
homo-oligomerization to large complexes, which occupy discrete cytoplasmic or 
nuclear sub-compartments (Reymond, et al. 2001). 
TRIM proteins differ from each other by their C-terminal domain, although most TRIM 
family members are characterized by a PRY, a SPRY, or combined PRY-SPRY 
domain (Ozato, et al. 2008, McNab, et al. 2010). The ~61 aa PRY and the ~140 aa 
SPRY domains together are also called B30.2 domain and are thought to mediate 
target binding. The SPRY domain is evolutionarily more ancient as it is found in 
animals, plants and fungi, whereas the B30.2 domain is only found in vertebrates 
with an adaptive immune system (Rhodes, et al. 2005). In humans, B30.2/PRY-
SPRY domains are only present at the C-terminus in TRIM proteins and in 
butyrophilin-related transmembrane glycoproteins (BTNs), which are receptors of the 
immunoglobulin superfamily (Henry, et al. 1997). Based on their C-terminal domain 
TRIM proteins are grouped into 11 classes, with different sub-cellular localization, 
cell-specific expression and function (Ozato, et al. 2008).  
 
1.3.1 TRIM proteins regulating immune responses 
Recently, members of the TRIM family have been implicated in regulating antiviral 
and antimicrobial immune responses. The importance of TRIM proteins in regulating 
immune homeostasis is also highlighted by inherited disorders that are associated 
with mutations in some of these genes. TRIM20/pyrin is mutated in the inflammatory 
disease familial Mediterranean fever (FMF) (French_FMF_Consortium 1997, 
International_FMF_Consortium 1997). The most prominent example for the immune 
function of a TRIM protein involves TRIM5 which is required for restricting retroviral 
infection in higher primates (reviewed in (Nakayama and Shioda 2010)).  
Important functions in the induction of innate immune responses have also been 
described for TRIM8, TRIM23, TRIM25, and TRIM56. TRIM8 decreases suppressor 
of cytokine signalling 1 (SOCS-1) protein levels leading to an inhibition of IFN 
signalling repression (Toniato, et al. 2002). TRIM23 induces K27-linked ubiquitination 
of NEMO necessary for NF-B and IRF3 activation downstream of TLR3 and RIG-I 
(Arimoto, et al. 2010). TRIM25 mediates K63-linked ubiquitination of the RIG-I CARD 
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in response to viral RNA leading to interaction with MAVS and antiviral signalling 
(Gack, et al. 2007), whereas TRIM56 is involved in dsDNA-mediated type I IFN 
activation (Tsuchida, et al. 2010).  
In contrast, TRIM proteins can also negatively regulate inflammatory responses: 
Mouse TRIM30 induces ubiquitination and degradation of TAB2 and TAB3 thereby 
inhibiting TLR-induced NF-B activation and has also been shown to negatively 
regulate NLRP3 inflammasome activation (Shi, et al. 2008, Hu, et al. 2010). 
Additionally, some TRIM proteins such as TRIM21/Ro52 are reported to have both 
positive as well as negative regulatory functions, depending on the experimental 
context (Kong, et al. 2007, Higgs, et al. 2008, Yang, et al. 2009, Higgs, et al. 2010).  
 
1.3.2 TRIM27 
TRIM27 is a member of the TRIM superfamily and exhibits the classical PRY-SPRY 
domain C-terminal of the RBCC motif (see Figure 1.4). It is a 58 kDa protein and is 
expressed as two isoforms with isoform TRIM27 being truncated within the PRY-
SPRY domain (aa position 358). TRIM27 was reported to be highly expressed in 
mouse spleen and thymus (Tezel, et al. 1999) and in cells of the hematopoietic 
compartment (Rajsbaum, et al. 2008). In contrast to many other TRIM proteins, 
TRIM27 expression is not altered by type I and II IFNs (Rajsbaum, et al. 2008, 
Carthagena, et al. 2009).  
TRIM27 exhibits either nuclear or cytosolic localization depending on the cell type, 
suggesting different functions in different tissues (Cao, et al. 1997, Tezel, et al. 
1999). A nuclear export sequence (NES) within the CC region is involved in different 
sub-cellular localization by differential masking of this theme (Harbers, et al. 2001). 
Furthermore, it has been shown that TRIM27 cytoplasmic localization is enhanced by 
protein kinase C (PKC) activation, although the signalling pathway remained 
unclear as TRIM27 is not a substrate of PKC (Harbers, et al. 2001). Originally, 
TRIM27 (alternatively named RET finger protein, RFP) was identified as a part of the 
rfp/ret transforming gene generated by DNA rearrangements, in which the RING 
finger is essential for the oncogenic potential (Hasegawa, et al. 1996). 
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Figure 1.4: TRIM27 domain architecture 
The classical RBCC motif at the TRIM27 N-terminus comprises a RING domain, a B-box 2 and a CC 
region. The C-terminal B30.2 domain is composed of a PRY and a SPRY domain. See also (Ozato, et 
al. 2008). 
 
Like other TRIM proteins, TRIM27 can form homo-oligomers involving the B-box and 
CC domain (Cao, et al. 1997). Hetero-oligomerization has been observed between 
TRIM27 and TRIM19/PML (promyelocytic leukemia gene) in PML nuclear bodies 
(Cao, et al. 1998). In addition, TRIM27 interaction with int-6/eIF3e has been 
described in PML nuclear bodies (Morris-Desbois, et al. 1999). Int-6/eIF3e is a 
subunit of the translation initiation factor eIF3, has also been shown to interact with 
the 26S proteasome in fission yeast (Yen, et al. 2003) and to regulate protein stability 
(Buchsbaum, et al. 2007, Chen, et al. 2007). Furthermore, TRIM27 interaction with 
members of the PIAS family results in targeting of TRIM27 to nuclear bodies by 
TRIM27 SUMOylation (Matsuura, et al. 2005). TRIM27 has also been shown to be a 
DNA-binding protein (Isomura, et al. 1992).  
Although the molecular function for TRIM27 remains largely elusive, TRIM27 has 
been shown to confer E3 ubiquitin ligase activity in vitro with the enzymes UBE2D1 
and D3 (Napolitano, et al. 2011) and also to possess SUMO E3 ligase activity (Chu 
and Yang 2011). Functionally TRIM27 is thought to play a role as a transcriptional 
repressor (Shimono, et al. 2000, Bloor, et al. 2005), as a negative regulator of NF-B 
and IFN-signalling pathways (Zha, et al. 2006), in apoptosis (Dho and Kwon 2003) 
and in cell cycle regulation (Patel and Ghiselli 2005).  
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1.4 Aim of this study 
The NLR family member NOD2 is critically involved in mediating antimicrobial innate 
immune responses. However, NOD2 regulation is still poorly understood. As TRIM 
proteins are emerging as important regulators of innate immune responses (Ozato, et 
al. 2008, McNab, et al. 2010), a yeast two-hybrid screen was conducted to identify 
TRIM proteins physically interacting with NOD2. The aim of the first project of this 
study was to verify the hits found in the screen and to further characterize their 
function on NOD2 and NOD2-mediated signalling pathways.  
The NOD2 ATPase domain seems to play an important role in regulating NOD2 
activity because mutations mapping to this domain are associated with elevated 
basal NOD2 activity in auto-inflammatory disorders, whereas mutation of the Walker 
A box inhibit NOD2 signalling. Therefore, the second project of this study aimed to 
analyse conserved amino acids within the ATPase domain of NOD1 and NOD2 in a 
comparative systematic mutational approach.  
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2 Materials and Methods 
2.1 Materials 
2.1.1 Reagents, chemicals and substances 
All chemicals were purchased from Roth, Merck or Sigma-Aldrich, unless otherwise 
noted.  
Reagent Manufacturer 
3 MM CHR Chromatography Paper Whatman 
Anti-FLAG M2 Affinity Gel Sigma-Aldrich 
ATP Sigma-Aldrich 
c-myc AC, clone 9E10 Santa Cruz Biotechnology 
Complete protease inhibitor cocktail tablets,  
EDTA-free 
Roche 
DAPI Invitrogen, Molecular Probes 
D-Luciferin Sigma-Aldrich 
dNTP Mix Fermentas 
Dulbecco’s modified Eagle’s medium Biochrom AG 
FBS Biowest 
FuGENE 6 Transfection Reagent Roche 
GeneRuler DNA Ladder, Low Range Fermentas 
Glutathione Sepharose Amersham Biosciences 
HiPerFect Transfection Reagent Qiagen 
illustra PuReTaq Ready-to-go PCR Beads GE Healthcare 
L-[35S]-methionine Perkin Elmer 
Lambda Hind III/phiX Hae III Marker Roth 
Leptomycin B Sigma-Aldrich 
Lipofectamin 2000 Reagent Invitrogen 
MDP InvivoGen 
PageRuler Prestained Protein Ladder Fermentas 
PBS (1x), for cell culture Biochrom AG 
Pefablock SC (AEBSF) Fluka Analytical 
Penicillin/Streptomycin Biochrom AG 
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Phalloidin-FITC Sigma-Aldrich 
ProLong Gold Antifade Reagent Invitrogen, Molecular Probes 
Protein G Sepharose GE Healthcare 
Protran Nitrocellulose Transfer Membrane, 0.2 µm Whatman 
Restore Plus Western Blot Stripping Buffer Thermo Scientific 
Rotiphorese Gel 30 (37.5:1) Roth 
RPMI 1640 medium Biochrom AG 
SuperSignal West Femto Maximum Sensitivity 
Substrate 
Thermo Scientific 
SuperSignal West Pico Luminol/Enhancer Solution Thermo Scientific 
TNF- InvivoGen 
Tri-DAP InvivoGen 
Trypsin/EDTA (10x) Biochrom AG 
X-tremeGENE 9 DNA Transfection Reagent Roche 
 
2.1.2 Kits 
Kit Manufacturer 
BD OptEIA Human IL-8 ELISA Set BD 
Bio-Rad DC Protein Assay Bio-Rad 
DuoSet ELISA (human IL-8 and IL-6) R&D Systems 
NucleoBond PC500 (Plasmid DNA preparation, Maxi) Macherey-Nagel 
NucleoSpin Extract II (PCR clean-up and gel extraction) Macherey-Nagel 
NucleoSpin Plasmid (Plasmid DNA preparation, Mini) Macherey-Nagel 
Qproteome Cell Compartment Kit Qiagen 
Rapid DNA Ligation Kit Fermentas 
RevertAid First Strand cDNA Synthesis Kit Fermentas 
RNeasy Mini  Qiagen 
TnT coupled reticulocyte lysate system Promega 
 
2.1.3 Buffers and media 
Buffers and media were autoclaved for 20 min at 121 °C or sterile filtered. All buffers 
and media were prepared with deionised millipore water and stored at RT, unless 
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otherwise noted. 1x buffers were prepared by 1:10 dilution of 10x buffers in deionised 
millipore water.  
Buffer Compound 
Blocking solution 5 % milk powder in 1x PBS or 1x TBS 
Buffer A 150 mM NaCl, 50 mM TRIS pH 7.5; before use add 
2 mM DTT 
Buffer B 500 mM NaCl, 50 mM TRIS pH 7.5 ; before use add 
2 mM DTT 
CBB 0.25 % CBB, 10 % acetic acid, 45 % ethanol 
Destain buffer 7 % acetic acid, 25 % ethanol 
D-Luciferin 0.27 mg/ml D-Luciferin in 50 mM Tris pH 8.0; -20 °C 
DNA loading dye (10x) 50 % Saccharose, 100 mM EDTA, 0.25 % 
Bromphenolblue 
LB Agar plates 1 L LB Medium + 1.5 % Bacto-Agar, supplemented with 
appropriate antibiotics (50 µg/ml Kanamycin, 100 µg/ml 
Ampicillin); 4 °C 
LB Medium 10 g Bacto-Tryptone, 5 g Bacto-Yeast extract, 10 g NaCl, 
1 L H2O 
Lower TRIS 1.5 M TRIS, 0.4 % SDS, pH 8.8 
Lysis buffer 25 mM TRIS pH 8.0, 8 mM MgCl2, 15 % glycerol, 1 % 
Triton X-100; before use add 1 mM DTT; 4 °C 
NP40 lysis buffer 150 mM NaCl, 50 mM TRIS pH 7.4, 1 % NP40; 4 °C, 
freshly add protease- and phosphatase inhibitors 
ONPG development 
buffer 
1:4 dilution of ONPG stock solution in ONPG dilution 
buffer 
ONPG dilution buffer 60 mM Na2HPO4x2 H2O, 40 mM NaH2PO4, 10 mM KCl, 
1 mM MgSO4x7 H2O, pH 7.0 
ONPG stock solution 4 mg/ml ONPG in ONPG dilution buffer; 4 °C 
PBS (10x) 1.37 M NaCl, 26.82 mM KCl, 80.9 mM Na2HPO4x2 H2O, 
17.63 mM KH2PO4, pH 7.4 
PBST 1x PBS + 0.05 % Triton X-100 
Ponceau S 0.2 % Ponceau S, 3 % acetic acid 
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Reading buffer Lysis buffer supplemented with 1 mM DTT, 0.54 µg/ml D-
Luciferin, 1.33 mM ATP 
RIPA lysis buffer 150 mM NaCl, 50 mM TRIS pH 7.4, 1 % Triton X-100, 
0.1 % SDS, 0.5 % deoxycholic acid sodium salt ; 4 °C, 
freshly add protease- and phosphatase inhibitors 
SDS running buffer 
(10x) 
250 mM TRIS, 1.92 M glycine, 34.67 mM SDS 
SDS sample buffer (6x) 7 ml 0.5 M TRIS pH 6.8 containing 0.4 % SDS, 3 ml 
glycerol, 1 g SDS, 1.2 mg bromphenol blue; -20 °C, 
freshly add 60 µl -mercaptoethanol /1 ml sample buffer 
TBE (10x) 0.89 M TRIS, 0.89 M boric acid, 20 mM Na2EDTA pH 8.0 
TBS (10x) 50 mM TRIS, 150 mM NaCl, pH 7.5 
TBST 1x TBS + 0.05 % Triton X-100 
Transfer buffer (10x) 250 mM TRIS, 1.92 mM glycine 
Transfer buffer (1x) 1:10 dilution of 10x Transfer buffer + 20 % methanol 
Transformation buffer 15 mM CaCl2, 250 mM KCl, 10 mM PIPES, 55 mM 
MnCl2x4 H2O, pH 6,7; sterile filtered 
Triton buffer 100 mM NaCl, 10 mM HEPES pH 5.6, 1 % Triton-X-100 
Triton lysis buffer 150 mM NaCl, 50 mM TRIS pH 7.4, 1 % Triton X-100 ; 
4 °C, freshly add protease- and phosphatase inhibitors 
Upper TRIS 0.5 M TRIS, 0.4 % SDS, pH 6.8 
 
2.1.4 Enzymes 
All restriction enzymes were purchased from Fermentas.  
Enzyme Manufacturer 
Pfu DNA Polymerase Fermentas 
PfuTurbo DNA Polymerase AD Statagene 
Phusion Finnzymes, BioLabs 
T4 DNA Polymerase Fermentas 
T7 RNA Polymerase Promega 
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2.1.5 Antibodies 
Primary Antibodies 
Antigen Type Clone Dilution Source 
Actin 
Rabbit 
polyclonal 
A2066 WB 1:500 Sigma-Aldrich 
Flag 
Mouse 
monoclonal 
 
WB 1:2000 
IF 1:20,000 
Stratagene 
GAPDH 
Rabbit 
polyclonal 
FL-335 WB 1:1000 
Santa Cruz 
Biotechnology 
HA 
Rabbit 
polyclonal 
Y-11 WB 1:500 
Santa Cruz 
Biotechnology 
HA 
Mouse 
monoclonal 
12CA5 WB 1:1000 Roche 
Lamin A/C 
Rabbit 
polyclonal 
 WB 1:500 
Cell Signaling 
Technology 
Myc 
Rabbit 
polyclonal 
A-14 WB 1:1000 
Santa Cruz 
Biotechnology 
Myc 
Mouse 
monoclonal 
9E10 
WB 1:1000 
IF 1:1000 
Sigma-Aldrich 
NOD1 Rat monoclonal 7B10 WB 1:100 
(Kufer, et al. 
2008) 
NOD2 Rat monoclonal 4A11 WB 1:100 
(Kufer, et al. 
2006b) 
RIP2 
Rabbit 
polyclonal 
 WB 1:500 
Cayman 
Chemicals 
TRIM27 
Rabbit 
polyclonal 
Y-11 
WB 1:400 
IF 1:500 
IBL 
Ub 
Mouse 
monoclonal 
P4D1 WB 1:1000 
Santa Cruz 
Biotechnology 
Ub K48-specific 
Mouse 
monoclonal 
Apu2 WB 1:1000 Millipore 
Ub K63-specific 
Mouse 
monoclonal 
Apu3 WB 1:1000 Millipore 
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Secondary Antibodies 
Antigen Type Label Dilution Source 
Mouse IgG Goat HRP WB 1:4000 
Bio-Rad 
Laboratories 
Mouse IgG,  
LC-specific 
Goat HRP WB 1:4000 
Jackson 
ImmunoResearch 
Rabbit IgG Goat HRP WB 1:4000 
Bio-Rad 
Laboratories 
Rabbit IgG,   
LC-specific 
Mouse 
monoclonal 
HRP WB 1:4000 
Jackson 
ImmunoResearch 
Rat IgG Goat HRP WB 1:4000 
Jackson 
ImmunoResearch 
Mouse IgG Goat AlexaFluor 488 IF 1:250 
Invitrogen, 
Molecular Probes 
Mouse IgG Goat AlexaFluor 546 IF 1:250 
Invitrogen, 
Molecular Probes 
Rabbit IgG Goat AlexaFluor 546 IF 1:250 
Invitrogen, 
Molecular Probes 
Rabbit IgG Goat AlexaFluor 405 IF 1:250 
Invitrogen, 
Molecular Probes 
 
 
2.1.6 Bacteria 
Strain Genotype Reference 
E. coli 
DH5 
F- 80lacZM15 (lacZYA-argF)U169 deoR 
recA1 endA1 hsdR17 (rk-, mk+) phoA supE44 
thi-1 gyrA96 relA1 - 
Invitrogen 
E. coli 
XL1Blue 
recA1 endA1 gyrA96 thi-1 hsdR17 supE44 
relA1 lac [F’ proAB laclqZM15 Tn10 (Tetr)] Stratagene 
E. coli 
BL21(DE3)-pLysS 
F-, ompT, hsdSB (rB-, mB-), dcm, gal, (DE3), 
pLysS, Cmr 
Stratagene 
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2.1.7 Cell lines 
Cell line Characteristics Reference (No) 
HEK293T 
Human embryonic kidney cells transformed with 
adenovirus type 5 and expressing simian virus 
40 large T antigen 
ATCC  
(CRL 11268) 
HeLa Human epithelial cervix adenocarcinoma cells 
ATCC  
(CCL 2) 
THP1 
Human peripheral blood monocytic cell line 
from acute monocytic leukaemia 
ATCC 
(TIB 202) 
 
2.1.8 Plasmids 
Vector Insert Tag Reference 
NF-B reporter Ig-
luciferase 
- - (Munoz, et al. 1994) 
pcDNA3 - - Invitrogen 
pcDNA3.1/3xmyc-A, -B 
and -C 
- Myc 
H. Sillje (MPI Biochemistry, 
Martinsried) 
pcDNA3.1/3xmyc-B TRIM27 B30.2 Myc This study 
pcDNA3.1/3xmyc-B TRIM27 WT Myc This study 
pcDNA3.1/3xmyc-B TRIM27 B30.2 Myc This study 
pcDNA3.1/3xmyc-B TRIM27 RING Myc This study 
pcDNA3.1/3xmyc-B 
TRIM27 
RING+BBox Myc This study 
pcDNA3.1/3xmyc-C NOD1 WT Myc 
A. Neerincx  
(Universität zu Köln) 
pcDNA3.1/3xmyc-C NOD2 WT Myc 
A. Neerincx, 
(Universität zu Köln) 
pcDNA3.1/3xmyc-C NOD2 K305R Myc 
A. Neerincx,  
(Universität zu Köln) 
pcDNA3.1/3xmyc-C TRIM27 WT Myc This study 
pcDNA3.1/3xmyc-C 
TRIM27 
CC16/31AA 
Myc This study 
pcDNA--Gal - - (Kufer, et al. 2006b) 
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pCMV-SPORT 6 Human TRIM27 - imaGenes 
pCMV-Tag2A, B and C - Flag Stratagene 
pCMV-Tag2B NOD1 WT Flag (Kufer, et al. 2008) 
pCMV-Tag2B NOD1 K208R Flag (Kufer, et al. 2008) 
pCMV-Tag2B NOD1 K208A Flag (Zurek, et al. 2011b) 
pCMV-Tag2B NOD1 D284A Flag (Zurek, et al. 2011b) 
pCMV-Tag2B NOD1 D287A Flag (Zurek, et al. 2011b) 
pCMV-Tag2B NOD1 E288A Flag (Zurek, et al. 2011b) 
pCMV-Tag2B NOD1 R333A Flag (Zurek, et al. 2011b) 
pCMV-Tag2B NOD1 P391A Flag (Zurek, et al. 2011b) 
pCMV-Tag2B NOD1 H517A Flag (Zurek, et al. 2011b) 
pCMV-Tag2B NOD2 WT Flag (Kufer, et al. 2006b) 
pCMV-Tag2B NOD2 K305R Flag (Kufer, et al. 2006b) 
pCMV-Tag2B NOD2 D379A Flag (Zurek, et al. 2011b) 
pCMV-Tag2B NOD2 D382A Flag (Zurek, et al. 2011b) 
pCMV-Tag2B NOD2 D382E Flag (Zurek, et al. 2011b) 
pCMV-Tag2B NOD2 E383A Flag (Zurek, et al. 2011b) 
pCMV-Tag2B NOD2 E383K Flag (Zurek, et al. 2011b) 
pCMV-Tag2B NOD2 R426A Flag (Zurek, et al. 2011b) 
pCMV-Tag2B NOD2 P486A Flag (Zurek, et al. 2011b) 
pCMV-Tag2B NOD2 H603A Flag (Zurek, et al. 2011b) 
pCMV-Tag2B NOD2 CARD Flag (Kufer, et al. 2006b) 
pCMV-Tag2B NOD2 CARD Flag (Kufer, et al. 2006b) 
pCMV-Tag2B NOD2 NBD Flag (Kufer, et al. 2006b) 
pCMV-Tag2B NOD2 LRR Flag (Kufer, et al. 2006b) 
pCMV-Tag2B NOD2 LRR Flag (Kufer, et al. 2006b) 
pCR3.V72-Met-VSV RIP2 VSV 
M. Thome  
(University of Lausanne) 
pGEX-II - GST 
I. Roux  
(Institut Pasteur, Paris) 
pGEX-II TRIM27 WT GST This study 
pGEX-II TRIM27 RING GST This study 
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pGEX-II 
TRIM27  
RING+B-box GST This study 
pRK5-HA Ubiquitin WT HA Addgene 
pUNO Human IKK HA InvivoGen 
 
2.1.9 Oligonucleotides 
Primers were synthesized by MWG-Biotech AG. RT-PCR primers for TRIM27 were 
purchased from Qiagen (QT00051954). 
Primer Application Sequence (5’-3’) 
GAPDH_fwd RT-PCR GGTATCGTGGAAGGACTCATGAC
GAPDH_rev RT-PCR ATGCCAGTGAGCTTCCCGTTCAG 
Myco_fwd Mycoplasma detection CACCATCTGTCACTCTGTTAACC 
Myco_rev Mycoplasma detection GGAGCAAACAGGATTAGATACCC 
Seq_NOD2_fwd1 NOD2 sequencing TGGAGAACATGCTGGACCTG 
Seq_NOD2_fwd2 NOD2 sequencing AGTGCATGGCCAAACCACTC 
Seq_NOD2_fwd3 NOD2 sequencing AGGAACTGTTGCTGCAGGAG 
TRIM27_aa1_fwd 
Cloning of TRIM27 
deletion constructs 
GCGCGGATCCGATGGCCTCCGG
GAGTGTGG 
TRIM27_aa133_fwd 
Cloning of TRIM27 
deletion constructs 
GCGCGGATCCGGAGGAGGCGGT
GGAGGGC 
TRIM27_aa295_rev 
Cloning of TRIM27 
deletion constructs 
GCGCGAATTCTGTGAACTGCTTT
AGACTCTCCG 
TRIM27_aa296_fwd 
Cloning of TRIM27 
deletion constructs 
GCGCGGATCCGGAAAAAATGCA
GTCAGATATGGA 
TRIM27_aa513_rev 
Cloning of TRIM27 
deletion constructs 
GCGCGAATTCTCAAGGGGAGGT
CTCCATGG 
TRIM27_aa63_fwd 
Cloning of TRIM27 
deletion constructs 
GCGCGGATCCGAGGCACATGCG
GCCCAACC 
TRIM27_Bam_fwd 
Cloning of TRIM27 into 
pCMV-Tag2B, BamHI 
GCGCGGATCCATGGCCTCCGGG
AGTGTG 
TRIM27_C16A_fwd 
Site-directed 
mutagenesis: TRIM27 E3
CAGCAGGAGACCACCGCCCCCG
TGTGCCTGCA 
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TRIM27_C31A_fwd 
Site-directed 
mutagenesis: TRIM27 E3
CCCATGATGCTCGACGCCGGCC
ATAACATCTG 
TRIM27_Eco_rev 
Cloning of TRIM27 into 
pCMV-Tag2B, EcoRI 
GCGCGAATTCTCAAGGGGAGGT
CTCCATGG 
 
2.1.10 siRNA 
siRNA Target sequence (5’-3’) 
Company 
(Name; Number) 
CTR  
Qiagen 
(AllStars Negative CTR, 1027281) 
NOD2 CTGCCACATGCAAGAAGTATA 
Qiagen 
(CARD15_3; SI00133049) 
TRIM27-1 AAGACTCAGTGTGCAGAAAAG 
Qiagen 
(Zha, et al. 2006) 
TRIM27-3 CAGAACCAGCTCGACCATTTA 
Qiagen 
(Hs_RFP_6, SI03062794) 
 
2.1.11 Technical equipment and software 
Technical equipment Supplier 
Biofuge Pico Heraeus Instruments GmbH  
Centrifuge 5415R Eppendorf  
FV-1000 laser scanning microscope 
(objective: PlanApo, x60/1.40 oil, ∞/0.17) 
Olympus  
Gel electrophoresis Bio-Rad Laboratories 
Luminescent Image Analyzer, LAS-4000 Fujifilm 
Luminometer Centro XS3 LB960 Berthold Technologies 
Megafuge 1.0 Heraeus Instruments GmbH  
Microtiter plate reader Photometer Anthos Micosysteme GmbH  
Multifuge 4KR Heraeus Instruments GmbH  
Nano Photometer™ Implen GmbH  
OD600 DiluPhotometer™ Implen GmbH  
PhosphorImager Bio-Rad Laboratories  
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Thermocycler MWG-Biotech  
Trans Blot SD, Semi-dry Transfer cell Bio-Rad Laboratories  
 
Software Supplier 
Adobe Acrobat Pro Adobe Systems GmbH 
Adobe Illustrator CS5 Adobe Systems GmbH 
Adobe Photoshop CS5 Adobe Systems GmbH 
EndNote X Thomson Reuters 
FV10-ASW 1.6 Olympus 
Microsoft Office 2003 Microsoft 
WCIF ImageJ (Rasband 2007) 
 
 
2.2 Methods 
2.2.1 Cell biological methods 
Cell culture 
HEK293T and HeLa cells were cultivated at 37 °C in a 5 % CO2 atmosphere in 
Dulbecco’s modified Eagle’s medium (DMEM) supplemented with 10 % heat-
inactivated fetal bovine serum (FBS), penicillin and streptomycin (100 IU/ml and 
100 mg/ml, respectively). THP1 cells were cultivated in RPMI 1640 supplemented as 
described above (supplemented media are subsequently referred to as medium). 
Cells were continuously tested for absence of mycoplasma infection by PCR.  
To freeze cells, they were centrifuged for 5 min at 1000 rpm and RT and the pellet 
was resuspended in medium supplemented with 10 % DMSO. 1 ml aliquots were 
frozen o/n at -80 °C in an isopropanol-containing box.  
To thaw cells, they were incubated at 37 °C until thawed and subsequently 10 ml 
medium was added. After centrifugation for 5 min at 1000 rpm and RT the pellet was 
resuspended in fresh medium and the cells were transferred into a cell culture dish 
and cultured as described above.  
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Transient DNA transfection 
For transient DNA transfection cells were seeded in DMEM without antibiotics into 
the adequate cell culture dish 24 h prior to transfection in order to reach a cell density 
of about 60-70 %. For transfection Lipofectamin 2000 (2.5 µl/1 µg DNA) or FuGENE6 
(3 µl/1 µg DNA) were used according to the manufacturer’s instructions.  
 
siRNA transfection 
For siRNA transfection in THP1 cells 2x105 cells/well were seeded in 500 µl medium 
in 24-well plates and differentiated with 0.1 µM PMA. 24 h later medium was 
removed and replaced by 100 µl fresh medium. Transfection mixes were prepared 
using 100 nM siRNA, 6 µl HiPerFect and 100 µl medium without supplementaries per 
well. After 5-10 min at RT transfection mixes were added to the cells. 6 h later 400 µl 
medium were added to the cells. The medium was changed one day after 
transfection. 72 h after siRNA transfection cells were stimulated o/n with 10 µM MDP 
or left unstimulated. Supernatants were collected and IL-8 secretion was determined 
by ELISA. Cell lysates were subjected to Western blot analysis for knock-down 
control.  
 
Luciferase reporter gene assay 
3x104 HEK293T cells per well were seeded in 96-well plates and transfected with 
8.6 ng -galactosidase, 13 ng luciferase NF-B-reporter, different amounts of Flag-
NOD1 or Flag-NOD2 (0.1, 0.5, 1 ng) or 0.1 ng NOD2 or 10 ng IKK expression 
plasmids either with or without myc-TRIM27 as indicated, added up with pcDNA to 
51 ng total DNA using FuGene6 (Roche) (see also (Zurek, et al. 2011a)). Cells were 
directly stimulated with 500 nM Tri-DAP, 50 nM MDP or 10 ng/ml TNF or left 
unstimulated, as indicated. After 16 h, cells were lysed in luciferase lysis buffer and 
luciferase activity was measured using a standard plate luminometer. Standard 
deviation (SD) was calculated from triplets and luciferase activity was normalized as 
a ratio to -galactosidase activity.  
Significance was assessed with a two-sided Student’s t-test (*, P<0.05; **, P<0.01; 
***, P<0.005).  
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Indirect immunofluorescence 
For indirect immunofluorescence microscopy, HeLa cells were seeded in 24-well 
plates on glass cover slips and transiently transfected with 0.8 µg of expression 
plasmids, as indicated using Lipofectamin 2000 transfection reagent according to the 
manufacturer’s instructions. After 24 h, cells were fixed with 3 % paraformaldehyde 
(PFA) in PBS for 10 min and permeabilized with 0.5 % Triton X-100 in cold PBS for 
5 min. Cells were blocked in 3 % bovine serum albumin (BSA) in PBS for 20 min and 
incubated successively in primary and secondary antibodies. Primary antibody: 
mouse anti-Flag (1:20,000), rabbit anti-TRIM27 (1:500) and mouse anti-myc 
(1:1000). Secondary antibody: goat anti-rabbit AlexaFluor 546 (1:250) and goat anti-
mouse AlexaFluor 488 (1:250). DNA was stained with DAPI (5 µg/ml) and F-actin 
with Phalloidin-FITC (2.5 µg/ml). Cells were mounted in ProLong Gold antifade 
reagent. Image acquisition of z-stacks was performed on an Olympus FV-1000 laser 
scanning microscope (objective: Olympus PlanApo, 60x/1.40 oil, ∞/0.17) and 
processed using ImageJ software (Rasband 2007). 
 
2.2.2 Molecular biological methods 
Mycoplasma PCR 
Cell culture supernatants were cooked for 5 min at 100 °C, briefly centrifuged and 
transferred on ice. 1 µl cell culture supernatant, 0.8 µl each Myco forward and 
reverse primer and 22.4 µl H2O were mixed with illustra PuReTaq Ready-to-go PCR 
beads and the PCR was run with the following protocol. PCR products were 
subsequently analysed by 2% agarose gel electrophoresis. 
Time Temperature No of cycles 
2 min 94 °C  
2 min 57 °C  
2 min 72 °C  
30 sec 92 °C 34x 
1 min 57 °C  
1 min 72 °C  
4 min 72 °C  
∞ 4 °C  
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Production of chemical competent bacteria 
500 ml LB medium were inoculated with 1.5 ml of an E. coli DH5 preparatory 
culture. Bacteria were grown until OD600=0.3-0.6 at 20 °C and 100 rpm. Bacteria 
were cooled for 10 min on ice and centrifuged for 15 min at 4000 rpm and 2 °C. The 
pellet was subsequently washed with 150 ml ice cold transformation buffer and 
centrifuged. The pellet was then resuspended in 40 ml transformation buffer and 3 ml 
DMSO. 500 µl aliquots were snap-frozen in liquid nitrogen and stored at -80 °C.  
 
Bacterial transformation 
50 µl chemical competent E. coli DH5 were transformed with ~100 ng plasmid DNA. 
Bacteria and DNA were incubated 30 min on ice and subsequently for 1 min at 42 °C. 
After cool down on ice, bacteria were directly plated on LB-agar plates containing 
100 µg/ml ampicillin when transformed with a plasmid carrying an ampicillin 
resistance marker. When the transformed plasmid contains a kanamycin resistance 
marker bacteria were diluted in 250 µl LB medium and incubated for 45 min at 37 °C 
before plated on LB-agar plates containing 50 µg/ml kanamycin. Bacteria were grown 
o/n at 37 °C. 
 
Isolation of plasmid DNA from E. coli 
Bacteria were cultured o/n at 37 °C in 5 ml (Miniprep) or 100 ml (Maxiprep) LB 
medium supplemented with the appropriate antibiotic. Isolation of plasmid DNA was 
performed using the NucleoBond PC20 or PC500 plasmid preparation kit according 
to the manufacturer’s instructions. The Maxiprep DNA was solved in ~200 µl 10 mM 
TRIS pH 8. Concentration and purity were determined using a nanodrop photometer 
measuring absorbance at 260 and 280 nm.  
 
Isolation of RNA from human cell lines 
RNA was isolated from human cell lines using the RNeasy Mini kit according to 
manufacturer’s instructions. RNA was eluted with RNase-free water. Concentration 
and purity were determined using a nanodrop photometer measuring absorbance at 
260 and 280 nm. 
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Reverse transcription of RNA 
Reverse transcription of 1 µg isolated RNA into cDNA was performed using the 
RevertAid First Strand cDNA Synthesis kit and oligo-dT primer according to 
manufacturer’s instructions. 
 
End-point RT-PCR 
PCRs of cDNA templates were performed according to the following protocol. The 
number of cycles depends on the gene and is indicated for each experiment. 
Reaction mixes were prepared on ice. PCR products were subsequently analysed by 
agarose gel electrophoresis. 
 
Substance Volume 
Taq buffer (+KCl, -MgCl2) [10x] 5 µl 
MgCl2 [25 mM] 4 µl 
dNTPs [10 mM] 1 µl 
Taq DNA polymerase [5 U/µl] 0.5 µl 
Primer fwd 1 µl [10 pmol/µl] (GAPDH) 
5 µl [10x] (TRIM27) 
Primer rev  1 µl [10 pmol/µl] (GAPDH) 
5 µl [10x] (TRIM27) 
cDNA 1 µl (GAPDH) / 
2 µl (TRIM27) 
H2O Up to 50 µl 
 
PCR was run according to the following program. 
Time Temperature No of cycles 
15 min 95 °C  
15 sec 94 °C 25-30x 
30 sec 55 °C  
30 sec 72 °C  
5 min 72 °C  
∞ 4 °C  
 
Restriction digestion of plasmid DNA 
The required amount of plasmid DNA was digested by 5 U/µg DNA of the appropriate 
restriction enzyme for 2 h. Buffer and temperature conditions were adjusted 
according to the enzymes used.  
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Agarose gel electrophoresis 
PCR products and digested plasmid DNA were separated and analysed by agarose 
gel electrophoresis. Agarose (1-2 %) was dissolved and boiled in 1x TBE. After 
cooling down the gel was poured into a gel tray and ~0.5 µg/ml ethidiumbromide was 
added. Samples were diluted with 10x DNA loading dye and loaded onto the gel. 5 µl 
GeneRuler Low Range DNA Ladder or Lambda Hind III/phiX Hae III Marker were 
used as standards. Samples were run for 30-60 min at 80 V and detected and/or cut 
out under UV light.  
 
Ligation of DNA fragments 
The digested DNA fragment was ligated into the linearised vector with an 
insert:vector ratio of 3:1 using the Rapid DNA Ligation kit according to the 
manufacturer’s instructions. For a negative control H2O instead of insert was used.  
 
Site-directed mutagenesis 
Point mutations were introduced by PCR using the QuikChange site-directed 
mutagenesis procedure (Stratagene). Primers used are listed above. Reaction mixes 
were prepared on ice according to the following protocol. 
 
Substance Volume 
Phusion 25 µl 
Plasmid DNA [100 ng/µl] 0.5 µl 
Primer fwd [10 pmol/µl] 1.2 µl 
Primer rev [10 pmol/µl] 1.2 µl 
H2O Up to 50 µl 
 
PCR was run according to the following program. 
Time Temperature No of cycles 
30 sec 95 °C  
10 sec 98 °C 20x 
30 sec 65 °C  
3:45 min 72 °C  
∞ 4 °C  
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To digest the parental plasmid DNA, 1.5 µl Dpn I were added to the PCR reaction 
mix and incubated for 2 h at 37 °C. Subsequently 50 µl chemical competent bacteria 
were transformed with 2 µl digested PCR reaction mix.  
 
2.2.3 Biochemical methods 
Yeast two-hybrid screen 
Binary two-hybrid screening was performed as described by Gyuris et al. (Gyuris, et 
al. 1993). Briefly, the bait plasmids (pEG202) express the cDNA fused directionally to 
the first 202 residues of LexA under the control of the constitutive ADH promoter. 
Prey plasmids (pJG4-5) express the cDNA fused to the B42 activation domain, the 
SV40T nuclear localization signal and an HA-tag under the control of the inducible 
GAL1 promoter. EGY42/EGY48 diploid strain was generated by mating for every 
pairwise combination. Six LexA-operators lacZ in the pSH18-34 vector and a genome 
integrated 4 LexA-operators LEU2 are used as reporters. The expression of two 
reporters was used to establish the interaction, blue-turning colonies and growth in 
the absence of Leu.  
 
Expression and purification of recombinant protein from E. coli 
TRIM27 and its deletion constructs were expressed as amino-terminal glutathione S-
transferase (GST)-fusion proteins in Rosetta2 (DE3) pLys cells following overnight 
isopropyl 1-thio--D-galactopyranoside (IPTG, 100 µM) induction at 20 °C. Bacteria 
were lysed by a freeze-and-thaw cycle followed by addition of 1.5 % sarkosyl and 
pulsed sonication. GST-fusion proteins were purified from bacterial extracts with 
glutathione-Sepharose beads, followed by extensive washing with buffer A, buffer B 
and again buffer A. TRIM27 protein bound to glutathione-Sepharose beads was 
stored in buffer A at -80 °C. 
 
In vitro transcription and translation 
In vitro transcription/translation (IVT) of NOD2 was performed in the presence of L-
[35S]-methionine (10 mCi/ml) using the TnT coupled reticulocyte lysate system and 
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T7 RNA polymerase according to the manufacturer’s instructions. IVT preparation 
was diluted three times in PBS and incubated with recombinant TRIM27 protein 
bound to glutathione-Sepharose beads for 2 h at 4 °C. Beads were precipitated and 
washed five times with RIPA buffer before SDS loading buffer containing -
mercaptoethanol was added. Proteins were analysed by Laemmli sodium 
dodecylsulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and followed by 
Coomassie staining. Autoradiographs were recorded using a PhosphorImager.  
 
Protein concentration measurement 
Protein concentrations were determined using the Bio-Rad DC Protein Assay 
according to the manufacturer’s instructions.  
 
IL-8 ELISA 
Secretion of IL-8 from human cells was determined by ELISA according to the 
manufacturer’s instructions. 
 
Co-immunoprecipitation 
For immunoprecipitation, HEK293T cells were seeded in 6 cm dishes and transiently 
transfected with 1 µg of each plasmid as indicated using Lipofectamin 2000 or 
FuGENE6. After 24 h incubation cells were lysed in NP40 lysis buffer or RIPA lysis 
buffer containing phosphatase inhibitors (20 µM -glycerophosphate, 5 mM NaF, 
100 µM Na3VO4), protease inhibitors (Complete) and 2 mM EDTA. Lysates were 
cleared for 20 min at 14,000 g and 4 °C. Flag-tagged NOD2 was immunoprecipitated 
with anti-Flag beads (M2 agarose), myc-tagged TRIM27 with anti-myc beads (c-myc 
AC, clone 9E10) for 3 h at 4 °C. Beads were precipitated and washed five times with 
lysis buffer before SDS loading buffer containing -mercaptoethanol was added. For 
ubiquitination analysis, 1 M NaCl was added to the washing buffer. Typically, 10 
times more precipitate than input was loaded onto the gel. Proteins were separated 
by SDS-PAGE and subsequently transferred on nitrocellulose membrane by semi-dry 
Western blotting.  
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Subcellular fractionation 
Isolation of membrane and cytosolic fractions was conducted as described (Barnich, 
et al. 2005a). Briefly, HEK293T cells were seeded in 6 cm cell-culture dishes and 
transiently transfected with 1 µg plasmid as indicated using Lipofectamine 2000. The 
cells were lysed in 300 µl Triton buffer supplemented with 2 mM EDTA, 4 mM 
Na3VO4, 40 mM NaF and protease inhibitor cocktail (Complete). The cytosolic 
fraction was obtained by centrifugation for 30 min at 10,000 g and 4 °C. 
Subsequently, the pellet was resuspended in 200 μl of Triton buffer containing 1 % 
SDS and was sonicated for 120 sec. After 5 min of centrifugation at 10,000 g and 
4 °C, the resulting supernatant was collected. Equal amounts of proteins were 
subjected to SDS-PAGE and Western blot. 
Isolation of cytosolic and nuclear fractions was performed using the Qproteome Cell 
Compartment kit according to the manufacturer’s instructions.  
The purity of the extracts was verified by immunoblotting using antibodies detecting 
cytosolic GAPDH or nuclear lamin A/C.  
 
SDS-PAGE 
Proteins were separated by SDS-PAGE (Laemmli 1970). Resolving and stacking gel 
were produced according to the following protocol. Samples were diluted in 6x 
Laemmli sample buffer containing -mercaptoethanol, boiled for 5 min at 95 °C and 
loaded onto the gel. 2 µl PageRuler Prestained Protein Ladder was used as 
standard. Samples were run at 120 V until they reach the resolving gel and 
subsequently at 195 V until the dye front completely drained off the gel.  
 Resolving gel Stacking gel 
 7.5 % 10 % 5 ml 
H2O [ml] 2.8 2.1 4.5 
Lower TRIS [ml] 5 - 
Upper TRIS [ml] - 0.625 
Acrylamide [ml] 1.9 2.5 0.325 
TEMED [µl] 25 12.5 
10 % APS [µl] 50 25 
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Western blot 
Proteins separated by SDS-PAGE were subsequently transferred for 30-40 min at 
15 V onto nitrocellulose membrane by semi-dry Western blotting. Blotting efficiency 
was controlled by Ponceau-S staining. Membranes were blocked for a minimum of 
30 min at RT with blocking solution. Membranes were incubated successively with 
primary and secondary antibody. All antibodies were diluted in blocking solution. 
After incubation with antibody, membranes were washed three times with PBST or 
TBST. Proteins were detected by final incubation with SuperSignal West Pico 
Chemiluminescent Substrate or Femto Maximum Sensitivity Substrate. Signals were 
recorded on an electronic imaging system (LAS4000, Fujifilm).  
 
Coomassie staining 
Proteins were separated by SDS-PAGE and the gel was subsequently incubated in 
Coomassie brilliant blue (CBB) for 30 min at RT followed by incubation in destain 
buffer for 30 min at RT. The gel was further destained in H2O. The gel was dried 
between cellophane for ~1 h at 80 °C in a drying plant.  
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3 Results 
3.1 Characterization of TRIM27 as a new interaction partner of 
NOD2 
3.1.1 TRIM27 is a new interaction partner of NOD2 
Members of the TRIM protein family are emerging as important regulators of innate 
immune responses. We were interested in whether TRIM proteins could contribute to 
the NOD2 signalling pathway and regulate NOD2 activity. To search for TRIM 
proteins that physically interact with human NOD2, a binary yeast two-hybrid screen 
was conducted with most human TRIM proteins as bait and NOD2 as prey. This 
identified interactions of NOD2 with TRIM8, TRIM27, and TRIM50 (Figure 1.2). Of 
note, homo-interactions for all TRIM proteins were observed indicating the correct 
folding as previously reported (Reymond, et al. 2001). 
 
 
Figure 3.1: Yeast two-hybrid screen 
Results of a yeast two-hybrid screen using NOD2 full length (NOD2 fl) and several TRIM proteins as 
bait and prey, as indicated. x, weak interaction; XX, strong interaction. Screen performed by L. 
Napolitano and G. Meroni. 
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Next, these interactions were verified in co-immunoprecipitation experiments in 
human cells. To this end, co-immunoprecipitations experiments in HEK293T cells 
expressing Flag-NOD2 and Myc-tagged TRIM proteins were performed using anti-
Flag beads. A strong interaction of NOD2 with TRIM27 was observed (Figure 3.2A), 
but no robust interaction was identified with the other TRIM proteins tested (data not 
shown). To assess the specificity of this interaction TRIM27 was tested for NOD1 
binding. NOD1 is another member of the NLR family that is closely related to NOD2. 
As shown in Figure 3.2A, NOD1 had only low affinity for TRIM27. Reciprocal co-
immunoprecipitations confirmed a strong interaction of TRIM27 with NOD2, but not 
with NOD1 (Figure 3.2B).  
 
 
Figure 3.2: Co-immunoprecipitation of NOD2 and TRIM27 
To verify NOD2-TRIM27 interaction, HEK293T cells were transfected with Myc-TRIM27 and Flag-
NOD1 or –NOD2. 24 h later, lysates were subjected to immunoprecipitation using anti-Flag (A) or anti-
Myc beads (B). Western blots of immunoprecipitates (IP) and total lysates (Input) were performed 
using the indicated antibodies. 
 
To establish this interaction for endogenous TRIM27, several cell lines were tested 
for the amount of endogenous TRIM27 using endpoint RT-PCR to find an appropriate 
cell system. Because HEK293T cells strongly express TRIM27 (Figure 3.3A), these 
cells were transfected with Flag-NOD2. Subsequently NOD2 was immunoprecipitated 
using anti-Flag beads. Endogenous TRIM27 co-precipitated with NOD2 (Figure 
3.3B), validating the NOD2-TRIM27 interaction for endogenous TRIM27.  
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Figure 3.3: TRIM27 mRNA expression in different cell lines 
(A) To define TRIM27 expression in different cell lines, end-point RT-PCR analysis of TRIM27 mRNA 
was performed. Amplification of GAPDH served as control. (B) To determine NOD2 interaction with 
endogenous TRIM27, HEK293T cells were transfected with Flag-NOD2. 24 h later, lysates were 
subjected to immunoprecipitation using anti-Flag beads and subsequently detected with the indicated 
antibodies. 
 
To elucidate which of the protein domains mediated the NOD2-TRIM27 interaction, a 
series of co-immunoprecipitation experiments was performed with NOD2 deletion 
mutants lacking the two CARD domains (CARDs) or the LRRs (LRR) or 
comprising only the CARD (CARDs) or NBD (NBD) domains (depicted in Figure 
3.4A, upper panels). NOD2 binding to TRIM27 was found to be independent of the 
CARD domains and the LRRs. Instead, the NOD2 NBD domain was sufficient to 
mediate interaction (Figure 3.4A, lower panels). Of note, binding of TRIM27 to NOD2 
LRR appeared to be stronger than to wild type NOD2. Next, TRIM27 domains 
needed for NOD2 binding were determined. TRIM27 constructs lacking the RING 
domain (R), lacking both RING and B-box domains (R+BB), TRIM27 missing the 
C-terminal PRY-SPRY domain (P-S) or comprising only this domain (P-S) were 
used (depicted in Figure 3.4B, upper panels). Deletion of the RING or both RING and 
B-box domains did not abolish the interaction with NOD2. In contrast, no NOD2 
binding to TRIM27 PRY-SPRY was observed (Figure 3.4B, lower panels). The 
expression of TRIM27 PRY-SPRY was weak, hence NOD2 binding at low affinity 
cannot formally be excluded (see Input panel in Figure 3.4B). However, a strong 
interaction of NOD2 with the TRIM27 PRY-SPRY domain alone was observed, 
showing that this domain is at least sufficient for NOD2 binding.  
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Figure 3.4: NOD2 NBD and TRIM27 PRY-SPRY domain are necessary for interaction 
(A) The depicted NOD2 deletion constructs (top panels) were used to map the domains required for 
TRIM27 binding. Each of the NOD2 mutants shown was transfected with Myc-TRIM27 in HEK293T 
cells. Lysates were subjected to immunoprecipitation using anti-Flag beads and probed with the 
indicated antibodies. (B) The depicted TRIM27 deletion constructs (top panels) were used to map the 
domains required for NOD2 binding. Each of the TRIM27 mutants shown was transfected with or 
without Flag-NOD2 in HEK293T cells. Lysates were subjected to immunoprecipitation using anti-Flag 
beads and probed with the indicated antibodies. 
 
To investigate if the NOD2-TRIM27 interaction was direct or dependent on adaptor 
molecules, direct protein-protein interaction assays were performed. To this end, in 
vitro transcribed and translated NOD2 was incubated with recombinant expressed 
GST-tagged TRIM27 protein bound to glutathione-Sepharose. NOD2 strongly bound 
to TRIM27 WT and TRIM27 RING and also to a somewhat weaker extent to 
TRIM27 RING+B-box. No non-specific binding was observed to GST alone, which 
was used as a control (Figure 3.5). 
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Figure 3.5: NOD2-TRIM27 binding is direct  
To test whether NOD2-TRIM27 binding is direct, in vitro transcribed and translated L-[35S]-
methionine-labelled NOD2 was incubated with recombinant GST-tagged TRIM27 protein (WT, RING, 
RING+B-box) or GST alone bound to glutathione-Sepharose beads. Both, the Coomassie stained gel 
(bottom) and the autoradiograph (top) are shown. 
 
NOD2 is activated by MDP, a bacterial peptidoglycan fragment. To explore whether 
activation of NOD2 by MDP has an influence on NOD2-TRIM27 complex formation, 
co-immunoprecipitations were performed in HEK293T cells expressing Flag-NOD2 
and Myc-TRIM27 stimulated with 10 µM MDP for 1, 2 or 3 h. Binding of TRIM27 to 
NOD2 was enhanced about 2-fold 3 h after MDP stimulation compared to untreated 
controls (Figure 3.6).  
Collectively, these findings demonstrated that TRIM27 is a new direct interaction 
partner of NOD2 and that this interaction is modulated by NOD2 activation.  
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Figure 3.6: MDP enhanced NOD2-TRIM27 binding 
To test whether NOD2-TRIM27 binding is influenced by NOD2 activation, HEK293T cells were 
transfected with Myc-TRIM27 and Flag-NOD1 or -NOD2. 24 h post-transfection, cells were stimulated 
with 10 µM MDP for 1, 2, or 3 h, as indicated. Lysates were subjected to immunoprecipitation using 
anti-Flag beads and probed using the indicated antibodies. For densitometric analysis, TRIM27 IP-
signals were normalized to input signals. The ratio of IP to input signals is shown in fold.  
 
3.1.2 TRIM27 promotes K48-linked ubiquitination and proteasomal 
degradation of NOD2 
Recently, TRIM27 has been shown to interact with a subset of E2 enzymes and to 
possess E3 ubiquitin ligase activity in vitro (Napolitano, et al. 2011). To investigate if 
TRIM27 can ubiquitinate NOD2, we first asked if NOD2 is subjected to ubiquitination 
in human cells. HEK293T cells were transfected with Flag-NOD2 or Flag-NOD1 as a 
control, followed by immunoprecipitation of the Flag-tagged proteins under stringent 
washing conditions. At steady-state conditions poly-ubiquitination was detected for 
NOD2 but not for NOD1 or in control IPs with the matrix alone (Figure 3.7A, left 
panel). Of note, we observed a single mono-ubiquitination band for both, NOD1 and 
NOD2.  
To decipher the type of ubiquitin linkage on NOD2, K48- or K63-linkage specific anti-
ubiquitin antibodies were used. The results show that the NOD2 ubiquitin chains 
were predominantly K48-linked (Figure 3.7A, middle and right panel). Given that 
TRIM27 was found to physically interact with NOD2, the next step was to determine 
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whether TRIM27 has an influence on NOD2 ubiquitination. To this end, HEK293T 
cells were transfected with Flag-NOD2, Myc-TRIM27 WT and HA-ubiquitin. The 
ubiquitin signal in NOD2 precipitates, detected either by anti-HA or the K48-linkage 
specific antibody, was increased upon over-expression of TRIM27 (Figure 3.7B). In 
contrast, over-expression of a TRIM27 E3 ligase-deficient mutant (named ‘TRIM27 
E3’) in which the two conserved catalytic cysteine residues within the TRIM27 RING 
domain (C16 and C31) were mutated to alanine, significantly reduced NOD2 
ubiquitination compared to TRIM27 WT (Figure 3.7B). Of note, TRIM27 E3 still bound 
NOD2 to the same extent as TRIM27 WT, indicating that the mutation did not affect 
binding affinity.  
 
 
Figure 3.7: NOD2 is ubiquitinated with K48-linked ubiquitin chains 
(A) To determine NOD2 ubiquitination, HEK293T cells were transfected with Flag-NOD1 or –NOD2. 
Lysates were subjected to immunoprecipitation using anti-Flag beads and Western blots of 
immunoprecipitates were performed using the indicated antibodies. Experiment was done by I. 
Schoultz. (B) To test if TRIM27 influences NOD2 ubiquitination, HEK293T cells were transfected with 
Flag-NOD2 and HA-ubiquitin together with or without Myc-TRIM27 WT or E3 mutant. Lysates were 
subjected to immunoprecipitation using anti-Flag beads and Western blots of immunoprecipitates (IP) 
and total lysates (Input) were performed using the indicated antibodies. Ubiquitin signals were 
detected using a HA- or a K48-specific ubiquitin antibody.  
 
K48-linked ubiquitination of proteins usually targets them for degradation by the 26S 
proteasome (Hershko and Ciechanover 1998). To investigate if NOD2 is subjected to 
proteasomal degradation, HEK293T cells transfected with small amounts of Flag-
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NOD2 were treated with cycloheximide (CHX) to block protein neosynthesis and 
changes in NOD2 protein levels were monitored by Western blot analysis. This 
showed that NOD2 was readily degraded in a time-dependent manner (Figure 3.8A, 
top). Of note, NOD1 was not subjected to rapid protein turn-over (data not shown). 
TRIM27 WT over-expression did not significantly influence the kinetics of NOD2 
degradation (Figure 3.8A, top).  
 
 
Figure 3.8: TRIM27 contributes to degradation of NOD2 
(A) To examine, if NOD2 stability is influenced by TRIM27 over-expression, HEK293T cells seeded in 
6-well plates were transfected with 0.25 µg Flag-NOD2 and 0.25 µg Myc-TRIM27 WT, E3 mutant or 
empty vector (CTR). 24 h post-transfection, cells were treated with 30 µg/ml cycloheximide (CHX) for 
0, 1, 3 or 6 h, as indicated. Western blot analysis (top) of total cell lysates was performed using the 
indicated antibodies. GAPDH served as loading control. Densitometric analysis (bottom) of the NOD2 
signals normalized to GAPDH signals. (B) To test if NOD2 degradation is inhibited by TRIM27 knock-
down, HEK293T cells were transfected with siCTR, siTRIM27-1 or siTRIM27-3 for 48 h, subsequently 
seeded in 6-well plates and transfected with 0.5 µg Flag-NOD2. 24 h later, cells were treated as 
described in (A). Western blot analysis of total cell lysates was performed using the indicated 
antibodies. GAPDH served as loading control. 
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In contrast, over-expression of the TRIM27 E3 ligase-deficient mutant strongly 
inhibited NOD2 degradation. This was further evaluated by densitometric analysis of 
the Flag-NOD2 signal normalized to the GAPDH loading control (Figure 3.8A, 
bottom). To elucidate the contribution of endogenous TRIM27 on NOD2 degradation, 
HEK293T cells were transfected with two different TRIM27-specific siRNA duplexes 
and NOD2 protein levels were monitored after blocking protein neosynthesis as 
described above. In cells transfected with scrambled control siRNA NOD2 was 
degraded (Figure 3.8B) as previously observed. In contrast, in cells treated with 
either of the two TRIM27-specific siRNA duplexes NOD2 degradation upon 
cycloheximide treatment was effectively inhibited (Figure 3.8B). Both siRNA duplexes 
reduced TRIM27 levels nearly to the detection limit as shown by Western blot 
analysis (Figure 3.8B). 
 
 
Figure 3.9: NOD2 is degraded by the proteasome 
(A) To test whether NOD2 is degraded by the proteasome, HEK293T cells were transfected with 
0.25 µg Flag-NOD2. 24 h post-transfection, cells were treated with 100 nM Bortezomib for 0, 1, 3 or 
6 h, as indicated. Western blot analysis of total cell lysates was performed using the indicated 
antibodies. GAPDH served as loading control. (B) To determine whether ubiquitinated NOD2 
accumulated after proteasome inhibition, HEK293T cells were seeded in 6-well plates and transfected 
with 0.5 µg HA-ubiquitin with or without 0.5 µg Flag-NOD2. 24 h post-transfection, cells were treated 
as described in A and lysates were subjected to immunoprecipitation using anti-Flag beads. Western 
blots of immunoprecipitates (IP) and total lysates (Input) were performed using the indicated 
antibodies. Actin served as loading control. 
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To determine whether NOD2 degradation occurred via the 26S proteasome, the 
proteasome inhibitor bortezomib (also called Velcade, MG-341 or PS-341) was used. 
NOD2 degradation was effectively inhibited in HEK293T cells transfected with Flag-
NOD2 and treated with 100 nM bortezomib (Figure 3.9A). Moreover, ubiquitinated 
NOD2 accumulated upon bortezomib treatment (Figure 3.9B).  
Taken together, these data revealed that K48-linked ubiquitination targets NOD2 for 
26S proteasomal degradation and that this process is dependent on functional 
TRIM27. 
 
3.1.3 TRIM27 is co-localized with NOD2 in the nucleus 
In HeLa cells TRIM27 predominantly exhibited nuclear localization (Cao, et al. 1997), 
whereas in HEK293T cells TRIM27 was also found at distinct sub-cellular structures 
(Figure 3.10). NOD2 is a cytoplasmic protein but can also localize to the plasma 
membrane (Barnich, et al. 2005a, Kufer, et al. 2006a, Legrand-Poels, et al. 2007), 
whereas other NLR proteins such as NLRC5 and CIITA also show nuclear 
localization (Cressman, et al. 1999, Harton, et al. 1999, Benko, et al. 2010, Meissner, 
et al. 2010).  
 
 
Figure 3.10: Localization of endogenous TRIM27 in HeLa and HEK293T cells 
Indirect immunofluorescence images of HeLa and HEK293T cells grown on cover slips. Fixed cells 
were permeabilized and stained with DAPI and anti-TRIM27 antibody, detected by AlexaFluor 546 
labelled secondary antibody. Images with signals for DAPI, TRIM27 and an overlay (blue: DAPI, red: 
TRIM27) are shown. Bars, 10 µm. 
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Previous experiments indicated that transiently over-expressed NOD2 is sometimes 
found in the nucleus (Kufer, et al. 2006a). To investigate this in more detail, 
immunofluorescence analyses were performed in HeLa cells transfected with Myc-
NOD2 WT. Nuclear shuttling of NOD2 could indicate low steady-state levels of NOD2 
protein in the nucleus. To prevent shuttling, nuclear export was blocked using the 
specific nuclear export inhibitor leptomycin B (LMB). In untreated samples, NOD2 WT 
localized mainly to the cytosol as well as partially to the nucleus (Figure 3.11A, upper 
panels). After LMB treatment NOD2 WT localized predominantly to the nucleus. In 
contrast, NOD1 and a NOD2 Walker A mutant (K305R) that is unable to induce NF-
B activation (Ogura, et al. 2001b, Zurek, et al. 2011b), did not localize to the 
nucleus, even after LMB treatment (Figure 3.11A, lower panels and B).  
To substantiate the results obtained by immunofluorescence analysis, cytosolic and 
nuclear fractionations were prepared from HEK293T cells expressing either Flag-
NOD1, -NOD2 or -NOD2 K305R. Immunoprecipitation of the Flag-tagged proteins 
from the cytosolic and nuclear fractions showed that a small portion of NOD2 already 
localized to the nucleus without LMB treatment (Figure 3.12, top). NOD2 nuclear 
localization increased about two-fold upon LMB treatment, as measured by 
normalized densitometric analysis (Figure 3.12, bottom). In contrast, all NOD1 and 
NOD2 K305R were found in the cytoplasm.  
The data clearly show that NOD2 is able to enter the nucleus in a Walker A-
dependent manner, which was also observed for NLRC5 (Neerincx, unpublished 
data) and CIITA (Harton, et al. 1999).  
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Figure 3.11: NOD2 WT localizes to the nucleus whereas NOD2 K305R or NOD1 do not 
(A) To analyse NOD2-TRIM27 co-localization in human cells, indirect immunofluorescence microscopy 
was performed. HeLa cells grown on cover slips were transfected with Myc-NOD2 WT (top panels) or 
Myc-NOD2 K305R (bottom panels). 24 h post-transfection, cells were treated with 50 nM Leptomycin 
B (LMB) for 4 h or left untreated. Fixed cells were permeabilized and stained with DAPI, anti-Myc and 
anti-TRIM27 antibody, detected by AlexaFluor 488 and AlexaFluor 546 labelled secondary antibody, 
respectively. Images with signals for the two antibodies, DAPI and an overlay (blue: DAPI, red: 
TRIM27, green: NOD2) are shown. Bars, 10 µm. (B) To test if NOD1 also localizes to the nucleus, 
indirect immunofluorescence microscopy was performed as described above. NOD1 images were 
generated by A. Neerincx.  
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Figure 3.12: NOD2 nuclear localization confirmed by biochemical fractionation 
To confirm NOD2 nuclear localization biochemically, HEK293T cells were transfected with Flag-NOD1, 
Flag-NOD2 WT or K305R. 24 h post-transfection cells were treated with 50 nM LMB for 4 h or left 
unstimulated. Cellular fractions were prepared and subsequently used for immunoprecipitation with 
anti-Flag beads. Western blot analysis of precipitated protein was performed using the indicated 
antibodies. For densitometric analysis, cytosolic and nuclear signals were normalized to GAPDH and 
Lamin A/C, respectively. The ratio of nuclear to cytosolic protein is shown as fold expression. 
 
3.1.4 TRIM27 negatively regulates NOD2 signalling 
Finally, the influence of TRIM27 on NOD2-mediated signalling was investigated. To 
this end NF-B luciferase assays were used in HEK293T cells co-transfected with 
different amounts of TRIM27. Over-expression of TRIM27 clearly reduced MDP-
induced NOD2-mediated NF-B activation in a dose-dependent manner (Figure 
3.13A). This effect of TRIM27 on NOD2-mediated signalling can not be explained by 
inhibition of RIP2-NOD2 complex formation as NOD2 was still able to bind RIP2 in 
the presence of TRIM27 (Figure 3.14).  
Importantly, TRIM27 over-expression had no influence on TNF-induced NF-B 
activation (Figure 3.13B). TNF is a potent activator of NF-B via signalling through 
the TNF receptor (TNFR)-pathway. The NOD2- and TNFR-signalling pathways 
converge at the level of the TAK1 complex that subsequently activates the IKK 
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complex (Chen and Goeddel 2002, Kufer 2008). Over-expression of IKK induces 
NF-B activation and this was used to conduct an epistatic analysis of TRIM27 
function. In line with the results obtained with NOD2- and TNF-mediated NF-B 
activation, TRIM27 over-expression had no effect on IKK-mediated NF-B signalling 
(Figure 3.13C), suggesting that TRIM27 acts at the level of NOD2. 
 
 
Figure 3.13: TRIM27 negatively regulates NOD2 signalling 
(A, B) To determine the influence of TRIM27 over-expression on MDP-induced NOD2-mediated (A) 
and on TNF-induced (B) NF-B activation, HEK293T cells were transfected with (A) or without (B) 
0.1 ng NOD2 and 0, 1, 5 or 10 ng TRIM27, as indicated, together with a NF-B luciferase reporter 
system. Cells were left unstimulated or stimulated for 16 h with 50 nM MDP (A) or 10 ng/ml TNF (B). 
Normalized luciferase activity (nRLU) of unstimulated (white bars) and stimulated (black bars) samples 
is shown. Values are means + SD. (C) The influence of TRIM27 on NF-B activation induced by over-
expression of components downstream of the NOD2 signalling cascade was tested. HEK293T cells 
were transfected with 10 ng IKK together with 0, 1, 5 or 10 ng TRIM27, as indicated, and a NF-B 
luciferase reporter system. Normalized luciferase activity (nRLU) is shown. Values are means + SD. 
(D) To determine the effect of TRIM27 knock-down, THP1 cells were differentiated and transfected 
with siCTR, siTRIM27-1 or siNOD2 for 72 h. Cells were then stimulated with 10 µM MDP o/n or left 
unstimulated. Supernatants were collected and secreted IL-8 was determined by ELISA. TRIM27 
knock-down efficiency is shown by Western blot analysis. *, P<0.05; ***, P<0.005. 
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Figure 3.14: NOD2 still binds RIP2 in the presence of TRIM27 
To determine whether NOD2 still binds RIP2 in the presence of TRIM27, HEK293T cells were 
transfected with Myc-TRIM27 WT or E3 and/or VSV-RIP2 together with or without Flag-NOD2. 
Lysates were subjected to immunoprecipitation using anti-Flag beads. Western blots of 
immunoprecipitates (IP) and total lysates (Input) were performed using the indicated antibodies. 
 
To determine the effect of endogenous TRIM27 on NOD2-mediated signalling, THP1 
cells, which possess a functional NOD2 signalling pathway were used (Uehara, et al. 
2005). THP1 is a monocytic cell line and can be differentiated to a macrophage-like 
state. They also express TRIM27 mRNA (Figure 3.3A). Differentiated THP1 cells 
were transfected with TRIM27- or NOD2-specific siRNA or control siRNA for 72 h and 
subsequently stimulated with 10 µM MDP. A hallmark of NOD2-mediated NF-B 
activation is the production of the pro-inflammatory cytokine IL-8. The amount of IL-8 
in the THP1 supernatants was determined by ELISA. TRIM27 knock-down increased 
MDP-induced IL-8 secretion, whereas NOD2 knock-down completely abolished IL-8 
secretion (Figure 3.13D). Western blot analysis confirmed the efficiency of TRIM27 
knock-down.  
About 30 % of the patients suffering from Crohn’s disease (CD) harbour mutations in 
nod2 (Hruz and Eckmann 2010). However, it is still under debate how nod2 
mutations contribute to disease development. CD patients suffer from a chronic 
inflammatory response of the gastrointestinal tract associated with excessive NF-B 
activation, suggesting that negative regulators – like TRIM27 – should be induced. To 
test this, RNA was isolated from colon biopsy samples of CD patients and healthy 
individuals as controls. qPCR analysis revealed significantly increased TRIM27 
mRNA expression in CD patients compared to healthy controls (Figure 3.15).  
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Collectively, these data support a role for TRIM27 as a specific negative regulator of 
NOD2-mediated signalling and suggest a role of TRIM27 in CD. 
 
 
Figure 3.15: TRIM27 expression in Crohn’s disease patients 
qPCR of TRIM27 mRNA expression in colonic biopsies derived from patients with Crohn’s disease 
and healthy controls (CTR) with no evidence of mucosal inflammation. Each symbol represents one 
patient. TRIM27 mRNA expression normalized to GAPDH is shown. *, P<0.05 (n=6). Experiment done 
by E. Bennek and G. Sellge. 
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3.2 Analysis of the NOD1 and NOD2 ATPase domain 
3.2.1 Characterization of active site residues critical for NOD1 and 
NOD2 signalling 
Sequence alignments of human NLR proteins and APAF1, previously revealed highly 
conserved amino acid residues in the NBD domain, which presumably affect ATPase 
activity (Proell, et al. 2008). To decipher the molecular details involved in NOD1 and 
NOD2 activation, single point mutants of these conserved residues were generated 
(amino acid exchanged to alanine) and analysed for their effect on elicitor- and auto-
activation-induced NF-B activity in luciferase reporter gene assays in HEK293T cells 
(summarized in Table 1, page 59). The localization of the mutated residues is 
depicted in Figure 3.16. 
 
 
Figure 3.16: NOD1 and NOD2 ATPase domain 
(A) Model of the NOD1 nucleotide-binding site with a bound ADP molecule and Mg2+ ion. Conserved 
sequence motifs Walker boxes A and B, extended Walker B box, Sensor 1, GxP and WH histidine are 
shown in sticks. Model generated by M. Proell and R. Schwarzenbacher. (B) Schematic representation 
of the domain architecture of NOD1 and NOD2. The NBD is composed of the NACHT (in blue), WH (in 
magenta) and SH domain. The magnification of the NACHT and WH domain indicates the position of 
the conserved amino acid residues analysed in this study. 
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Over-expression of NOD1 and NOD2 is known to induce auto-activation, therefore 
the amount of NOD1 and NOD2 was carefully titrated in preliminary assays (data not 
shown) and three established DNA concentrations were subsequently used for each 
construct. Importantly, comparable expression of all constructs was achieved as 
shown by Western blot analysis (Figure 3.17D).  
Early publications already reported that the Walker A (P-loop) lysine (GK[S/T]), which 
is responsible for nucleotide binding (Hanson and Whiteheart 2005, Proell, et al. 
2008), is essential for NOD1- and NOD2-mediated NF-B signalling (Inohara, et al. 
1999, Ogura, et al. 2001b). It was confirmed that mutation of the Walker A lysine to 
either alanine or arginine (NOD1: K208; NOD2: K305) resulted in unresponsiveness 
to elicitor stimulation and lack of auto-activation in both NOD1 and NOD2 (Figure 
3.17A, B).  
Similarly, mutation of the Mg2+-co-ordinating aspartate residue in the Walker B box 
(DGhDE) of NOD1 (D284) and NOD2 (D379) resulted in complete loss of NF-B 
activation (Figure 3.17A, B), demonstrating that both canonical ATPase features are 
essential for activation of NOD1 and NOD2. NLR proteins contain a modified Walker 
B box lacking the second acidic residue (DG instead of D[D/E]) that is usually 
responsible for priming of a water molecule required for ATP hydrolysis (Proell, et al. 
2008). However, in most NLR proteins, including NOD1 and NOD2, the Walker B box 
is followed by a highly conserved patch of acidic residues, the extended Walker B 
box (DGhDE), suggesting that these acidic residues can functionally compensate for 
the missing second aspartate of the canonical Walker B box. To investigate the 
function of this modified Walker B box, the corresponding amino acids in NOD1 and 
NOD2 were replaced by alanine. Mutation of the aspartate residue of the extended 
Walker B box (NOD1: D287; NOD2: D382) reduced elicitor-induced NF-B activation 
mediated by NOD1 by more than 50% compared to the wild type, whereas NOD2 
showed only residual activity. Both NOD1 and NOD2 exhibit complete loss of auto-
activation (Figure 3.17A, B). This indicates that the aspartate residue of the extended 
Walker B box is essential and might functionally complement the missing second 
acidic residue of the canonical Walker B box.  
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Figure 3.17: Functional analysis of conserved residues in NOD1- and NOD2-mediated NF-B 
activation 
(Legend continued on following page) 
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(Legend of Figure 3.17 / continued) 
NF-B activation of NOD1 (A) and NOD2 (B) WT and mutant proteins were assayed in HEK293T cells 
transfected with 0.1, 0.5 or 1 ng of the indicated plasmids together with a NF-B luciferase reporter 
system. Cells were left unstimulated or stimulated for 16 h with 500 nM Tri-DAP (A) or 50 mM MDP 
(B). Percentage of normalized luciferase activity relative to 1 ng Flag-NOD1 WT (A) or Flag-NOD2 WT 
(B) is shown. Values are means +SD. (C) NF-B activation of NOD2 WT, EOS- (D382E) and BS-
associated (E383K) NOD2 mutants. NF-B luciferase assay was conducted as described in (A) and 
(B). (D) Western blot analysis showing the expression levels of NOD1 and NOD2 constructs using 
anti-NOD1 7B10 and anti-Flag antibodies for NOD1 and NOD2, respectively (upper panels). GAPDH 
served as loading control (lower panels). 
 
The glutamate residue of the extended Walker B box in NOD1 (E288) was also found 
to be essential for NF-B activation and displayed an even stronger phenotype than 
the loss of the aspartate residue (Figure 3.17A). In sharp contrast, mutation of the 
corresponding amino acid in NOD2 (E383) led to significantly increased basal NF-B 
activation (Figure 3.17B). This unexpected finding indicated a different function of the 
extended Walker B box residues in NOD1 and NOD2 signalling. Indeed, this result 
fits very well with the fact that naturally occurring mutations in the extended Walker B 
box lead to auto-activation of NOD2, whereas such mutations have not yet been 
reported for NOD1. Mutations in the NOD2 extended Walker B box are linked with 
early-onset sarcoidosis (EOS; D382E/A612T) (Kanazawa, et al. 2005) and Blau 
syndrome (BS; E383K) (van Duist, et al. 2005), two severe auto-inflammatory human 
diseases associated with hyperactive NOD2. In the assay system used here, this 
phenotype was recapitulated. Both NOD2 D382E and NOD2 E383K led to enhanced 
auto-activation compared to the wild type, whereas a somewhat lower response was 
observed with MDP (Figure 3.17C). Of note, the EOS mutation D382E displayed less 
basal activation than the E383K mutation. This observation was attributed to the fact 
that the single mutant NOD2 D382E instead of the double mutant D382E/A612T 
usually found in patients (Kanazawa, et al. 2005) was used in this study. Since both 
aspartate (D) and glutamate (E) are acidic residues, we suggest that glutamate might 
partially adopt the function of D382. 
Next, the contribution of the conserved Sensor 1, GxP motif, and WH histidine to 
NOD1 and NOD2 activation was explored. The Sensor 1 motif is involved in co-
ordinating the -phosphate of ATP, whereas the conserved proline residue in the GxP 
motif is thought to interact with the adenine moiety of ATP (for review see (Hanson 
and Whiteheart 2005)). Mutation of the Sensor 1 in NOD1 (R333) resulted in 
complete loss of NF-B activation (Figure 3.17A), whereas the corresponding 
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mutation in NOD2 (R426) still showed residual NF-B activation in response to MDP 
(Figure 3.17B). Mutation of the conserved proline in the GxP motif abolished elicitor-
dependent NF-B activation in both NOD1 (P391) and NOD2 (P486) (Figure 3.17A, 
B). Furthermore, mutation of the WH histidine completely blocked NF-B activation 
by NOD1 (H517). In contrast, NOD2 H603A was still able to respond to MDP, albeit 
at reduced levels compared to the wild type and showed increased auto-activation 
(Figure 3.17B). The latter finding was similar to the results obtained when 
exchanging the glutamate in the extended Walker B box supporting our conclusion 
that NOD1 and NOD2 are differentially activated.  
 
Table 1: Overview of conserved motifs in the ATPase domain, their proposed function and the 
analysed residues in NOD1 (top) and NOD2 (bottom, italic) 
 
1 Ability to activate NF-B as determined in Figure 3.17A and B (-, no activity [<10% of WT]; +, 
residual activity [>10% of WT]; ++, less active than WT; +++, activity comparable to WT). 
2 Supposed to be involved in nucleotide binding/hydrolysis bound by the neighbouring molecule. 
 
Taken together, these results (summarized in Table 1) revealed that a functional 
Walker A and B box as well as Sensor 1 and GxP motif are crucial for NOD1 and 
NOD2 activation. Importantly, a function could be assigned to the extended Walker B 
box in NLRs. Furthermore, these data demonstrated that mutations of the extended 
Walker B box and the WH histidine have opposing effects on NOD1- and NOD2-
mediated signalling, indicating different mechanisms of activation and regulation.  
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3.2.2 NOD1 and NOD2 activation status is reflected by their sub-cellular 
localization 
Recently, it was reported that exogenously expressed active NOD1 and NOD2 
localizes to the plasma membrane in various human cells, which relates to auto-
activation of the over-expressed NLRs (Barnich, et al. 2005a, McDonald, et al. 2005, 
Lecine, et al. 2007, Kufer, et al. 2008). In order to complement the results of the NF-
B activation assays presented above, the sub-cellular localization of the NOD1 and 
NOD2 mutants was examined in HeLa cells by indirect immunofluorescence analysis. 
Figure 3.18A shows that only NOD1 WT localized to actin-rich regions at the plasma 
membrane, whereas all of the NOD1 mutants that did not show auto-activation in the 
NF-B reporter assays (NOD1 K208A, D284A, E288A, R333A, P391A, and H517A) 
were restricted to the cytoplasm. Accordingly, NOD1 D287A, which showed only 
elicitor-mediated activation, also failed to localize to the plasma membrane upon 
over-expression (Figure 3.18A).  
Indirect immunofluorescence analysis of NOD2 revealed increased membrane 
localization of the wild type, the highly auto-active NOD2 mutant E383A, and to a 
lesser extend NOD2 H603A (Figure 3.18B). The two disease-associated NOD2 
mutants D382E (EOS) and E383K (BS), which exhibited the highest auto-activation 
level in the NF-B assays were also recruited to the plasma membrane, whereas 
non-signalling active NOD2 mutants (NOD2 K305R, D379A, D382A, R426A, and 
P486A) exhibited an exclusively cytoplasmatic localization pattern (Figure 3.18B).  
 
 
 
 
 
Figure 3.18: Sub-cellular localization of NOD1 and NOD2 mutants 
Indirect immunofluorescence images of HeLa cells grown on cover slips were transfected with Flag-
NOD1 (A) or Flag-NOD2 (B) constructs. Fixed cells were permeabilized and stained with DAPI, 
Phalloidin-FITC and anti-Flag antibody, detected by AlexaFluor 546 labelled secondary antibody. 
Images with signals for NOD1 and NOD2 alone (upper panels) and an overlay (lower panels; blue: 
DAPI, red: NOD1 or NOD2, green: actin) are shown. Bars: 10 µm. 
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To confirm the differences in membrane association of the NOD1 and NOD2 mutants 
biochemically, membrane fractionations in HEK293T cells transfected with NOD1 and 
NOD2 mutants were performed. In agreement with the data presented above, NOD1 
and NOD2 wild type as well as the auto-activating mutants NOD2 E383A and NOD2 
H603A were present in the membrane fraction, whereas the non auto-activating 
mutants NOD1 K208A, NOD1 E288A and NOD1 H517A as well as NOD2 K305R 
and NOD2 D382A were only detectable in the cytosolic fractions (Figure 3.19).  
 
 
Figure 3.19: Cellular fractionation of NOD1 and NOD2 mutants 
HEK293T cells were transfected with NOD1 or NOD2 plasmids as indicated. 24 h later, cells were 
lysed, cytosolic (C) and membrane (M) fractions were prepared and subjected to Western blot analysis 
using anti-Flag antibody. GAPDH served as loading control. 
 
In summary, these data show that recruitment of NOD1 and NOD2 to the plasma 
membrane reflects their activation status in agreement with the results obtained in 
the NF-B reporter assays. 
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4 Discussion 
4.1 Analysis of the NOD1 and NOD2 ATPase domain 
The molecular details underlying NOD1 and NOD2 activation are still not fully 
understood. In particular the role of ATP hydrolysis in NLR signalling is unclear, 
despite the general perception that NLRs function as nucleotide binding proteins. 
Since no high resolution structural data on NLRs are available to date, the current 
model of NLR activation is deducted from their apoptotic relative APAF1 and from in 
vitro studies on purified NLRP1, NLRP3, NLRP12, and NLRC4 (Lu, et al. 2005, 
Duncan, et al. 2007, Faustin, et al. 2007, Ye, et al. 2008). According to these studies 
the general assumption has been that nucleotide binding is required for NLR protein 
function, i.e. the induction of molecular platforms to promote downstream signalling 
events. However, the exact role of nucleotide hydrolysis in the activation process is 
unclear. Danot et al. proposed a model for STAND ATPases comprising the following 
steps: (I) elicitor recognition, (II) conformational changes leading to a semi-opened 
state, (III) nucleotide exchange (ATP for ADP) to drive oligomerization, and (IV) 
deactivation of the signalling platform by ATP hydrolysis (Danot, et al. 2009). 
According to this model, an ATP hydrolysis step is necessary only to stop signalling 
and, consequently, mutations of residues crucial for ATP hydrolysis should result in 
auto-activation. Our data do not entirely support this model for NOD1 and NOD2, as 
they clearly show that mutation of most of the ATPase features including the Walker 
A and B box, GxP motif and Sensor 1 led to complete loss of signalling. The 
requirement of a functional Walker A box in NOD1 and NOD2 activation was already 
reported (Inohara, et al. 1999, Ogura, et al. 2001b). This indicates that nucleotide 
binding and likely an initial nucleotide hydrolysis step is essential for both NOD1 and 
NOD2 activation. Differences between NOD1 and NOD2 activation in our analysis 
were discovered in the WH histidine. Whereas mutation of NOD1 H517A resulted in 
complete loss of NF-B activation, NOD2 H603A showed reduced MDP-induced but 
higher basal NF-B activation compared to the wild type.  
Most NLR proteins contain a modified Walker B box lacking the second acidic 
residue and consecutively a highly conserved patch of acidic residues, the extended 
Walker B box (D[GAS]hDE). Although it was proposed that these acidic residues can 
functionally compensate for the missing one of the canonical Walker B box, this was 
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so far not experimentally tested. In a recent study Ye et al. used an NLRP12 Walker 
A/B box mutant in which the Walker A box and the first acidic residues of the 
canonical and extended Walker B box were mutated to alanine (GKS → AAA and 
DxxDE → AxxAE) (Ye, et al. 2008). This NLRP12 mutant displayed decreased ATP 
binding capacity and no ATPase activity compared to the wild type. However, this 
study did not identify the specific function of the individual residues involved. In the 
present work, a systematic mutational approach was chosen to also address this 
issue.  
Dissection of the extended Walker B box revealed a function for the first acidic 
residue in both NOD1 and NOD2 activation, although NOD1 D287A still showed 
reduced elicitor-mediated NF-B activation. While mutation of the second acidic 
residue in NOD1 (E288A) almost completely blocked NF-B activation, the 
corresponding residue in NOD2 (E383A) had different effects: NOD2 E383A 
exhibited significantly higher auto-activation compared to the wild type. This suggests 
that E383 is necessary for NOD2 deactivation rather than activation, possibly by 
retaining the NOD2 signalling platform in an “on” state incapable of returning into the 
dormant form. We propose that in contrast to NOD1, NOD2 uses an additional 
hydrolysis step for deactivation mediated by the second acidic residue of the 
extended Walker B box (E383). Importantly, a recently identified BS-associated 
mutation (E383K) also maps to this position (van Duist, et al. 2005) and results in 
increased basal NF-B activation compared to the wild type.  
A theoretical explanation for different NOD1 and NOD2 deactivation mechanisms 
could lie in their differences in oligomerization. Based on the overall similarity of NLR 
proteins with APAF1 and cryo-EM analysis of recombinant NLRP1 (Faustin, et al. 
2007), we hypothesize that NOD2 forms wheel-like oligomers where E383 is 
necessary for the second ATP hydrolysis step and NOD2 deactivation. Furthermore, 
NOD2 WH histidine H603 could be involved in this second ATP hydrolysis step of the 
neighbouring molecule as suggested for APAF1 (Hanson and Whiteheart 2005, 
Proell, et al. 2008). In contrast to NOD2, results obtained for NOD1, however, 
indicate that it might not form such multimeric signalling complexes, as the 
corresponding residues are not involved in its deactivation, but rather in the activation 
process. Therefore, NOD1 might use a mechanism other than ATP hydrolysis for 
deactivation. Indeed, the NOD1 CARD domain was recently reported to form dimers, 
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which could be involved in the formation of such a different signalling complex 
(Srimathi, et al. 2008).  
Unfortunately, we have not yet been successful in producing soluble recombinant 
NOD1 and NOD2 protein in sufficient amounts and purity to conduct in vitro ATPase 
assays and obtain structural information. Thus, most of these interpretations await 
experimental verification in vitro once the problems of protein expression are 
overcome. Nonetheless, these data support the idea that NOD2 is more prone to 
auto-activation as the corresponding residues of all gain-of-function mutations 
affecting the NOD2 NBD domain are non-functional in NOD1. Moreover, none of the 
mutations in the NOD1 NBD domain analysed in this study resulted in enhanced 
signalling. The sensitivity of NOD2 for auto-activation is in line with the findings that 
(1) in contrast to NOD2, no naturally occurring NOD1 mutations exhibiting higher 
auto-activation has been reported in the literature, that (2) there are more disease-
associated mutations found for NOD2 than NOD1 (Borzutzky, et al. 2009), that (3) 
NOD1 is expressed at basal levels in most tissues whereas NOD2 expression is 
more restricted to phagocytic and intestinal epithelial cells and can be induced by 
pathogenic stimuli (Ogura, et al. 2001b, Gutierrez, et al. 2002, Ogura, et al. 2003, 
Rosenstiel, et al. 2003, Oh, et al. 2005, Sabbah, et al. 2009), and that (4) more 
negative regulators are reported for NOD2 than for NOD1 (Kufer 2008, Lecat, et al. 
2010). One of these NOD2-specific negative regulators is the E3 ubiquitin ligase 
TRIM27 identified in this study (discussed below). Additionally, to obtain comparable 
auto-activation in transient transfection assays less NOD2 than NOD1 is required.  
In summary, we established a function for most ATPase signatures of NOD1 and 
NOD2 activation. We give evidence that mutations in the extended Walker B box and 
the WH histidine have opposing effects on NOD1- and NOD2-mediated signalling, 
suggesting different mechanisms for their activation and regulation. Finally, we 
showed that membrane localization correlated with signalling competence. Future 
research should shed light on the ATP binding and hydrolysis capacity of each 
mutant analysed in this study using recombinant NOD1 and NOD2 protein.  
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4.2 Characterization of TRIM27 as a new NOD2 interaction partner 
In this study the E3 ubiquitin ligase TRIM27 was identified as a new interaction 
partner of NOD2. Mapping studies indicated that NOD2 binds via its NBD domain to 
the TRIM27 B30.2/PRY-SPRY domain. The PRY-SPRY domain is most commonly 
found at the C-terminus of TRIM proteins (Ozato, et al. 2008). Of note, the TRIM27 
binding site of NOD2 correlates with the findings for other TRIM proteins: TRIM21 
(also called Ro52) binds its interaction partners IRF3 and IRF8 via the B30.2/PRY-
SPRY domain (Kong, et al. 2007, Higgs, et al. 2008, Yang, et al. 2009) and TRIM25 
binds RIG-I via the C-terminal SPRY domain (Gack, et al. 2007). TRIM20, better 
known as pyrin, regulates caspase-1 activation and IL-1β production by interacting 
with caspase-1 and ASC via its PRY-SPRY and PYD domain, respectively (Richards, 
et al. 2001, Chae, et al. 2003, Chae, et al. 2006). Mutations in the human TRIM20 
PRY-SPRY domain are associated with inherited familial Mediterranean fever (FMF) 
(French_FMF_Consortium 1997, International_FMF_Consortium 1997). Interestingly, 
mice are not able to phenocopy this effect as murine TRIM20 lacks the PRY-SPRY 
domain. Recently, it was shown that TRIM20 knock-in mice harbouring the mutant 
human PRY-SPRY domain reproduce the inflammatory phenotype found in patients. 
Additionally, they form ASC-dependent, NLRP3-independent inflammasomes, linking 
the TRIM20 PRY-SPRY domain to NLR protein functions (Chae, et al. 2011). 
Another intriguing example underscoring the involvement of PRY-SPRY domains in 
NLR regulation is found in zebrafish (Danio rerio). A certain class of NLR proteins in 
D. rerio comprises molecules harbouring a PRY-SPRY domain fused to the canonical 
NLR sequence (Laing, et al. 2008). Remarkably, PRY-SPRY domains from zebrafish 
NLRs are closely related to zebrafish TRIMs, suggesting domain shuffling during 
evolution (van der Aa, et al. 2009) and that TRIM and NLR proteins have been 
closely connected in evolution to function in innate immune responses.  
TRIM proteins are involved in the regulation of PRR and IFN signalling pathways. 
Regulation occurs mainly by ubiquitination of the receptors, components of the 
signalling cascades or transcription factors. TRIM-mediated ubiquitination events can 
either enhance immune response as shown e.g. for TRIM8, TRIM21, TRIM23, 
TRIM25 and TRIM56 (Toniato, et al. 2002, Gack, et al. 2007, Kong, et al. 2007, 
Yang, et al. 2009, Arimoto, et al. 2010, Tsuchida, et al. 2010) or inhibit them as 
shown for TRIM21 and TRIM30 (Higgs, et al. 2008, Shi, et al. 2008, Hu, et al. 
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2010). In this study, TRIM27 was also shown to be involved in PRR signalling by 
negatively regulating NOD2. It was observed that dependent on functional TRIM27, 
NOD2 is ubiquitinated by K48-linked ubiquitin chains. Although no poly-ubiquitin 
chains were detected on NOD1, the ubiquitin-specific antibody displayed a strong 
signal for both, NOD1 and NOD2 proteins, suggesting mono-ubiquitination events 
(Figure 3.7). This signal was neither observed with K48- nor K63-specific antibodies. 
Recently, CIITA mono-ubiquitination was shown to enhance transcriptional potency 
(Greer, et al. 2003), while poly-ubiquitination leads to proteasomal degradation of 
CIITA. Future research should clarify whether NOD1 and NOD2 mono-ubiquitination 
has a biological function.  
K48-linked ubiquitination usually targets proteins to degradation (Hershko and 
Ciechanover 1998), which is the function of some TRIM proteins in PRR and IFN 
signalling pathways: Mouse TRIM30 promotes ubiquitination and degradation – 
although not by proteasomal but rather by lysosomal degradation – of TAB2 and 
TAB3 thereby inhibiting TLR-induced NF-B activation (Shi, et al. 2008), whereas 
TRIM8 decreases SOCS-1 protein levels leading to an inhibition of IFN signalling 
repression (Toniato, et al. 2002). Ubiquitinated NOD2 is also targeted for 
proteasomal degradation, as shown by inhibition of the 26S proteasome using 
bortezomib (Figure 3.9). Although we cannot formally exclude the possibility that the 
observed ubiquitination signal is caused by other proteins co-precipitating with the 
NOD2 complex, NOD2 protein stability is effectively dependent on TRIM27. This is 
demonstrated by the finding that knock-down of endogenous TRIM27 as well as 
over-expression of TRIM27 E3 inhibited NOD2 degradation (Figure 3.8). Regulation 
of PRRs by ubiquitination and proteasomal degradation seems to be a common 
theme: the E3 ubiquitin ligase Triad3A is known to control TLR4 and TLR9 signalling 
(Chuang and Ulevitch 2004) and recently the plant PRR flagellin-sensing 2 (FLS2) 
has been also shown to be ubiquitinated and degraded by PUB12/13 in a negative 
feedback loop (Lu, et al. 2011). We could now demonstrate that NOD2 is also 
regulated via such control mechanism. Recently, TRIM27 has also been shown to 
confer SUMO E3 ligase activity (Chu and Yang 2011). However, we did not detect 
SUMOylated NOD2, questioning the notion that NOD2 is a substrate for TRIM27-
mediated SUMOylation (data not shown).  
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Luciferase assays in HEK293T cells showed that TRIM27 over-expression 
specifically reduces NOD2-mediated MDP-induced NF-B activation in a dose-
dependent manner, whereas TNF-induced NF-B activation was not affected (Figure 
3.13). The negative regulating effects of TRIM27 on NOD2 signalling are not 
necessarily explained by NOD2 degradation but might also be due to preventing 
adaptor protein recruitment to the NOD2 complex. However, TRIM27 did not inhibit 
the NOD2-RIP2 interaction. In contrast to our data, Zha et al. reported that TRIM27 
interacts with IKK, IKK, IKK and TBK1 to negatively regulate NF-B, IFN and 
ISRE activation induced by these kinases (Zha, et al. 2006). The discrepancies 
between the two studies remain unclear, although the observed effect by Zha et al. is 
independent of the RING domain.  
In contrast to most TRIM proteins, TRIM27 expression is not altered in response to 
type I and II IFNs (Rajsbaum, et al. 2008, Carthagena, et al. 2009). Among the TRIM 
proteins induced by type I and II IFNs, many have been shown to confer antiviral 
activity, although IFN-inducibility is not a prerequisite for antiviral activity (Reymond, 
et al. 2001, Carthagena, et al. 2009). Constitutively expressed TRIM proteins have 
also been shown to trigger antiviral immune responses. However, an influence of 
TRIM27 over-expression on Sendai virus-induced IFN activation was not observed 
(data not shown), although this was recently reported (Zha, et al. 2006). We therefore 
assume that TRIM27 involvement in antiviral responses is unlikely, but future 
research should address this in more detail.  
We showed that some mutations in the NBD domain of NOD2 can result in enhanced 
NF-B activation whereas these do not increase the activity of NOD1 (see above and 
(Zurek, et al. 2011b)). Thus, NOD2 is likely more prone to auto-activation than NOD1 
and needs to be more tightly controlled to prevent overwhelming inflammatory 
responses (see above). Here, another difference between NOD1 and NOD2 
regulation is noted: NOD2, but not NOD1, is tightly controlled by ubiquitination and 
subsequent proteasomal degradation depending on TRIM27 E3 ligase activity. This 
identifies TRIM27 as an essential negative regulator of NOD2-mediated inflammatory 
responses.  
The most frequent Crohn’s disease-associated NOD2 mutation is NOD2fs. This 
mutation is thought to cause NOD2 loss-of-function, which is also supported by 
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several publications showing decreased cytokine production by different cell types 
harbouring this mutation in response to MDP (Inohara, et al. 2003, Netea, et al. 2004, 
Netea, et al. 2005, Kramer, et al. 2006). Impaired -defensin production in the 
inflamed gastrointestinal tract of CD patients with the NOD2fs mutation (Wehkamp, et 
al. 2004) as well as accumulation of bacterial endotoxin in the intestinal tissue have 
been reported (Kosovac, et al. 2010). However, CD is characterized by high levels of 
NF-B activation and TNF production, and both anti-TNF therapy as well as NF-
B inhibitors are efficient in treating CD (Hruz and Eckmann 2010). This would rather 
suggest that CD-associated NOD2 mutations are gain-of-function mutations and 
promote inflammatory responses. Accordingly, a study using NOD2fs knock-in mice 
reported increased NF-B activation in response to MDP (Maeda, et al. 2005). 
However, these results are under debate and conflict with those found in patients and 
healthy individuals homozygous for the NOD2fs mutation (van Heel, et al. 2005). One 
hypothesis therefore suggests that the deficiencies in epithelial barrier function 
caused by NOD2 loss-of-function result in increased bacterial invasion and 
subsequent inflammation with impaired control mechanisms. Indeed, NOD2 
signalling has also been reported to down-regulate TLR2-mediated NF-B activation 
in mice. This regulatory mechanism was defective in mice with the NOD2fs mutation 
resulting in enhanced Th1 responses (Watanabe, et al. 2004). Moreover, the anti-
inflammatory cytokine IL-10 is decreased in CD patients with Nod2 mutations (Netea, 
et al. 2004). In this study, enhanced TRIM27 expression in the colon of CD patients 
was detected. Although the NOD2 status of the patients analysed is unknown, 
enhanced TRIM27 expression will limit NOD2 function. Two scenarios for TRIM27 
function in CD are conceivable: either TRIM27 negatively regulates inflammatory 
responses coming from hyperactive mutant NOD2 (in case of gain-of-function) or 
TRIM27 prevents additional inflammatory responses mediated by NOD2 WT. 
However, the role of TRIM27 in a NOD2 loss-of-function scenario remains puzzling. 
Of course, TRIM27 function in CD could also be independent of NOD2. Especially, 
since NOD2 is not the only CD susceptibility gene it would be interesting to correlate 
TRIM27 levels with the NOD2 status of CD patients. Clinically, the results identify 
TRIM27 as a new and promising target for treating NOD2-associated diseases. It is 
conceivable that targeting TRIM27 might be advantageous in Crohn’s disease, when 
NOD2 activity is altered.  
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In conclusion, these data suggest that TRIM27 acts in a negative feedback loop on 
NOD2, as NOD2-TRIM27 binding is enhanced after NOD2 activation by MDP (Figure 
3.6). The model drawn in Figure 1.2 summarizes TRIM27 function on NOD2.  
 
 
Figure 4.1: Model for TRIM27 function on NOD2 
MDP activates NOD2, leading to NF-B and MAPK signalling. Activation of NOD2 increases 
interaction with the E3 ubiquitin ligase TRIM27. This induces K48-linked ubiquitination and subsequent 
proteasomal degradation of NOD2. 
 
In addition, evidence was provided that NOD2, unlike NOD1, can shuttle to the 
nucleus (Figure 3.11 and Figure 3.12). Since endogenous NOD1 and NOD2 proteins 
are difficult to detect, this could thus far only be demonstrated for ectopically 
expressed proteins. Until now, only two other members of the human NLR family are 
known to shuttle to the nucleus. CIITA, one of the founding members of the NLR 
family, has long been recognized as a regulator of MHC class II gene expression by 
acting as a scaffold for DNA-binding transcription factor assembly in the nucleus 
(Steimle, et al. 1993, Zika and Ting 2005). Recently, NLRC5 has also been shown to 
localize to the nucleus and to regulate MHC class I expression (Meissner, et al. 
2010), although the exact function of NLRC5 in the nucleus remains controversial 
(Benko, et al. 2010). Nuclear import of macromolecules through the nuclear pore 
complex (NPC) is an active process and requires a nuclear localization signal (NLS) 
on the cargo protein. CIITA has been shown to possess three NLSs (Cressman, et 
al. 1999, Spilianakis, et al. 2000, Cressman, et al. 2001) and a bipartite NLS has also 
been identified in NLRC5 (Meissner, et al. 2010). However, preliminary sequence 
analysis failed to identify a bipartite NLS in NOD2. NOD2 recruitment to the nucleus 
could possibly be mediated by a so far unknown NLS sequence or carrier proteins. 
Nevertheless, we suppose that a small functional group of human NLR proteins with 
nuclear localization exists (Kufer and Sansonetti 2011). In common with CIITA and 
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NLRC5, NOD2 can be regarded as a member of this group possessing the ability to 
localize to the nucleus and/or having a function in gene expression.  
Nuclear translocation and functionality have also been shown for several NLR-related 
plant R proteins. For tobacco N, barley MLA, arabidopsis RPS4 and potato RX R 
proteins nuclear localization is essential for defence activation (Burch-Smith, et al. 
2007, Shen, et al. 2007, Tameling and Baulcombe 2007, Wirthmueller, et al. 2007). A 
revised model for R protein-mediated defence response suggests that pathogen 
recognition takes place in the cytoplasm, whereas transcriptional reprogramming to 
activate the immune response is carried out in the nucleus (Liu and Coaker 2008). 
For example, activated MLA has been shown to directly interact with repressive 
WRKY transcription factors in the nucleus and therefore enables defence gene 
transcription (Shen, et al. 2007). However, it is unlikely that plant R proteins elicit 
defence responses exclusively in the nucleus. For tobacco N, which confers 
resistance to Tobacco mosaic virus (TMV), MAP kinase activation in the cytosol is 
necessary for N-mediated resistance in addition to its nuclear functions (Jin, et al. 
2003, Liu, et al. 2003). NOD2 might also not only recognize pathogens and activate 
MAP kinases and NF-B in the cytosol, but possesses additional nuclear functions to 
mediate and control immune responses. TRIM27 is recruited to specific sub-nuclear 
compartments (Matsuura, et al. 2005) and was suggested as a transcriptional 
repressor (Shimono, et al. 2000, Bloor, et al. 2005). In analogy to the function of plant 
R proteins, one possibility is that TRIM27, in addition to its role in NOD2 regulation, is 
functionally involved in orchestrating NOD2 nuclear functions. It would be of great 
interest to further elucidate this issue.  
Taken together, we revealed the importance of the ATPase domain in NOD1 and 
NOD2 and found evidence for differential activation mechanisms of these two closely 
related NLR proteins. We identified TRIM27 as a new interaction partner specific for 
NOD2 using yeast two-hybrid screening and co-immunoprecipitation analysis. This 
interaction is direct and enhanced upon NOD2 activation. TRIM27 induces K48-
linked ubiquitination of NOD2, targeting it for proteasomal degradation. Thus, 
TRIM27 is critically involved in negatively regulating NOD2 activity. We also detected 
enhanced TRIM27 expression in Crohn’s disease patients. These findings identify a 
new and promising target for therapeutic modulation of NOD2 activity in this disease. 
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6 Abstract 
The nucleotide-binding domain and leucine-rich repeat containing gene (NLR) family 
member NOD2 is involved in mediating antimicrobial innate immune responses. 
Uncontrolled NOD2 activity can lead to severe inflammatory disorders, but the 
regulation of NOD2 is still poorly understood.  
The NOD2 ATPase domain seems to exhibit a crucial regulatory function. Mutations 
affecting conserved residues of this domain are linked to the auto-inflammatory 
diseases Blau syndrome and early-onset sarcoidosis, whereas mutation of the 
Walker A box lead to signalling repression. Conserved amino acids within the 
ATPase domain of NOD2 and the related NLR protein NOD1 were analysed in a 
systematic mutational approach. The results revealed that a functional Walker A and 
B box, GxP motif and Sensor 1 are important for both NOD1 and NOD2 activation, as 
mutation of these residues strongly impaired NF-B activation. This indicates that 
nucleotide binding and an initial nucleotide hydrolysis step are essential for both 
NOD1 and NOD2 activation. Furthermore, the data gave evidence that mutations in 
the extended Walker B box and the WH histidine have opposing effects on NOD1- 
and NOD2-mediated signalling. Whereas they were non-functional in NOD1, NOD2 
auto-activation was enhanced compared to the wild type. This led us to propose that 
NOD2 is more prone for auto-activation and need to be more tightly controlled than 
NOD1. 
In line with this assumption, NOD2, but not NOD1, was found to be subjected to rapid 
protein turnover involving ubiquitin-mediated proteasomal degradation. A yeast two-
hybrid screen identified TRIM27 as a new binding partner for NOD2. The specificity 
of this interaction was confirmed by reciprocal co-immunoprecipitation experiments in 
a human cell line. The interaction was mediated by the NOD2 nucleotide-binding 
domain (NBD) and the TRIM27 PRY-SPRY motif. TRIM27 is a RING domain E3 
ubiquitin ligase. NOD2, but not NOD1, was identified to be ubiquitinated with K48-
linked ubiquitin chains and subjected to proteasomal degradation dependent on 
functional TRIM27. Accordingly, TRIM27 negatively affected NOD2-mediated pro-
inflammatory responses. The NOD2-TRIM27 interaction was enhanced upon 
stimulation with the NOD2 agonist MDP. This suggests that TRIM27 is involved in a 
negative feed-back loop to control NOD2-mediated signalling. Of note, TRIM27 is a 
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nuclear protein in most human cells. This study demonstrated that also NOD2 can 
shuttle to the nucleus and co-localizes with TRIM27. 
NOD2 loss-of-function mutations are associated with Crohn’s disease. Analysis of 
colonic biopsies from Crohn’s disease patients revealed significantly enhanced 
TRIM27 mRNA expression, underscoring a physiological role of TRIM27 in regulating 
NOD2 signalling. We conclude that TRIM27 negatively regulates NOD2-mediated 
signalling by destabilization of NOD2 and suggest that TRIM27 could be a new and 
promising target for therapeutically intervention in NOD2-associated diseases. 
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7 Zusammenfassung 
NOD2 ist ein Mitglied der NLR-Proteinfamilie und an der Entwicklung angeborener 
Immunantworten beteiligt. Unkontrollierte NOD2-Aktivität kann zu schweren 
entzündlichen Krankheiten führen, allerdings ist bislang noch nicht ausreichend 
bekannt, wie NOD2 reguliert wird. 
Die ATPase Domäne in NOD2 besitzt eine wichtige regulatorische Funktion. 
Mutationen von konservierten Aminosäuren in dieser Domäne sind mit 
Autoimmunerkrankungen wie dem Blau-Syndrom und der early onset Sarkoidose 
verbunden, aber auch mit der Inhibierung des NOD2-Signalweges wie z.B. bei einer 
Mutation der Walker A Box. In einer systematischen Mutationsanalyse wurden 
konservierte Aminosäuren der ATPase Domäne von NOD2 und des verwandten 
Proteins NOD1 untersucht. Die Ergebnisse zeigten, dass für die Aktivierung von 
NOD1 und NOD2 sowohl eine funktionelle Walker A und B Box als auch das GxP-
Motiv und der Sensor 1 wichtig sind, da Mutationen von diesen die NF-B-
Aktivierung stark beeinträchtigten. Dies weist darauf hin, dass eine Nukleotid-
Bindung und ein initialer Nukleotid-Hydrolyseschritt für die Aktivierung von NOD1 und 
NOD2 notwendig sind. Weiterhin konnte gezeigt werden, dass Mutationen der 
erweiterten Walker B Box sowie des konservierten Histidin in der WH-Domäne 
(winged helix) unterschiedliche Auswirkungen auf die NOD1- und NOD2-Aktivierung 
haben. Während sie in NOD1 nicht mehr funktionell sind, führen sie bei NOD2 zu 
einer erhöhten Autoaktivierung im Vergleich zum Wildtyp. Wir nehmen daher an, 
dass NOD2 leichter autoaktiviert werden kann und besser als NOD1 kontrolliert 
werden muss.  
In Übereinstimmung mit dieser Annahme wurde gezeigt, dass NOD2 aber nicht 
NOD1 einem schnelleren Proteinumsatz unterliegt, welcher durch Ubiquitin-
vermittelten proteasomalen Abbau erfolgt. In einem Hefe-Zwei-Hybrid-Screen wurde 
TRIM27 als neuer Interaktionspartner von NOD2 identifiziert. Die Spezifität dieser 
Interaktion wurde durch reziproke Co-Immunoprezipitationsexperimente bestätigt. 
Die Interaktion erfolgt über die Nukleotid-bindende Domäne (NBD) von NOD2 und 
das TRIM27 PRY-SPRY-Motiv. TRIM27 ist eine RING-Domänen E3 Ubiquitin Ligase. 
Es wurde gezeigt, dass NOD2 – nicht jedoch NOD1 – abhängig von funktionellem 
TRIM27 mit K48-verlinkten Ubiquitinketten modifiziert wird, was wiederum zur 
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proteasomalen Degradation von NOD2 führt. Dementsprechend negativ beeinflusste 
TRIM27 die NOD2-vermittelten pro-inflammatorischen Immunantworten. Die NOD2-
TRIM27-Interaktion wurde durch die Stimulation mit dem NOD2-Agonisten MDP 
verstärkt. Dies deutet darauf hin, dass TRIM27 in einen negativen Feedback-Loop 
der den NOD2-Signalweg kontrolliert, involviert ist. In humanen Zellen ist TRIM27 
hauptsächlich im Zellkern lokalisiert. Es wurde gezeigt, dass auch NOD2 in den 
Zellkern transportiert werden kann und dort mit TRIM27 co-lokalisiert.  
NOD2-Mutationen, die zu einem Funktionsverlust von NOD2 führen, sind mit Morbus 
Crohn assoziiert. Kolonbiopsien von Morbus Crohn-Patienten zeigten eine signifikant 
erhöhte Expression von TRIM27 mRNA, was die physiologische Rolle von TRIM27 
bei der NOD2-Regulation verdeutlicht. Aus diesen Daten kann geschlossen werden, 
dass TRIM27 NOD2-vermittelte Immunreaktionen durch eine Destabilisierung von 
NOD2 negativ reguliert. TRIM27 könnte daher ein neuer, vielversprechender 
Angriffspunkt für therapeutische Maßnahmen bei NOD2-assoziierten Krankheiten 
sein.  
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